| ENSG00000198221.7 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.046153386 |
Resistant |
| ENSG00000215241.3 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.039620543 |
Resistant |
| ENSG00000225039.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.018605903 |
Resistant |
| ENSG00000226352.2 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.04384995 |
Resistant |
| ENSG00000226377.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.019573546 |
Resistant |
| ENSG00000226756.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.017911251 |
Resistant |
| ENSG00000228115.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.046745712 |
Resistant |
| ENSG00000228889.2 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.045614111 |
Resistant |
| ENSG00000229688.3 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.010917411 |
Resistant |
| ENSG00000232160.2 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.031280605 |
Resistant |
| ENSG00000233030.2 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.019377095 |
Resistant |
| ENSG00000234694.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.013297858 |
Resistant |
| ENSG00000237978.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.045471671 |
Resistant |
| ENSG00000241155.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.026796821 |
Resistant |
| ENSG00000246225.2 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.024001159 |
Resistant |
| ENSG00000249359.2 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.044478624 |
Resistant |
| ENSG00000249572.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.013388453 |
Resistant |
| ENSG00000250764.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.028278863 |
Resistant |
| ENSG00000250874.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.008949695 |
Resistant |
| ENSG00000251611.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.012820567 |
Resistant |
| ENSG00000253125.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.036088833 |
Resistant |
| ENSG00000259523.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.04120376 |
Resistant |
| ENSG00000259826.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.035811815 |
Resistant |
| ENSG00000260988.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.002120701 |
Resistant |
| ENSG00000261189.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.015693725 |
Resistant |
| ENSG00000261455.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.048803592 |
Resistant |
| ENSG00000261916.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.034558468 |
Resistant |
| ENSG00000262155.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.036296321 |
Resistant |
| ENSG00000263050.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.019928901 |
Resistant |
| ENSG00000266824.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.047519213 |
Resistant |
| ENSG00000267052.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.038073665 |
Resistant |
| ENSG00000270964.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.01980562 |
Resistant |
| ENSG00000272829.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.04701697 |
Resistant |
| ENSG00000272862.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.037942413 |
Resistant |
| ENSG00000273247.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.042860225 |
Resistant |
| ENSG00000196960.3 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.011942456 |
Resistant |
| ENSG00000225112.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.038839291 |
Resistant |
| ENSG00000225760.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.018967796 |
Resistant |
| ENSG00000227028.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.040544153 |
Resistant |
| ENSG00000228692.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.01170903 |
Resistant |
| ENSG00000229105.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.044122794 |
Resistant |
| ENSG00000232082.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.032359978 |
Resistant |
| ENSG00000233661.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.049528579 |
Resistant |
| ENSG00000235770.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.02656137 |
Resistant |
| ENSG00000237036.4 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.028635881 |
Resistant |
| ENSG00000246090.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.041473354 |
Resistant |
| ENSG00000246379.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.040621428 |
Resistant |
| ENSG00000249898.3 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.029143196 |
Resistant |
| ENSG00000253744.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.041200934 |
Resistant |
| ENSG00000253875.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.020762031 |
Resistant |
| ENSG00000254164.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.027663463 |
Resistant |
| ENSG00000254340.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.033469658 |
Resistant |
| ENSG00000256742.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.027772801 |
Resistant |
| ENSG00000257910.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.023217875 |
Resistant |
| ENSG00000258935.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.023028836 |
Resistant |
| ENSG00000259366.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.049100699 |
Resistant |
| ENSG00000267390.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.040331768 |
Resistant |
| ENSG00000267581.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.0362193 |
Resistant |
| ENSG00000271743.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.016532302 |
Resistant |
| ENSG00000272755.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.007751679 |
Resistant |
| ENSG00000273123.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.025845488 |
Resistant |
| ENSG00000185203.7 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.008194669 |
Resistant |
| ENSG00000203808.6 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035373332 |
Resistant |
| ENSG00000224761.2 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040943829 |
Resistant |
| ENSG00000227014.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042430665 |
Resistant |
| ENSG00000229702.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.034860858 |
Resistant |
| ENSG00000229999.2 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031896688 |
Resistant |
| ENSG00000230061.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045992661 |
Resistant |
| ENSG00000230074.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.003376966 |
Resistant |
| ENSG00000231028.4 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.020338506 |
Resistant |
| ENSG00000235499.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049902075 |
Resistant |
| ENSG00000245685.2 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038537108 |
Resistant |
| ENSG00000247516.3 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041941896 |
Resistant |
| ENSG00000250007.2 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013265456 |
Resistant |
| ENSG00000251143.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039921413 |
Resistant |
| ENSG00000254248.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03935807 |
Resistant |
| ENSG00000254510.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026879136 |
Resistant |
| ENSG00000260186.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.043353724 |
Resistant |
| ENSG00000261766.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036214131 |
Resistant |
| ENSG00000263860.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036368925 |
Resistant |
| ENSG00000264469.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.009780299 |
Resistant |
| ENSG00000265688.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.033293856 |
Resistant |
| ENSG00000267040.2 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.025709101 |
Resistant |
| ENSG00000267268.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026434047 |
Resistant |
| ENSG00000267651.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028163225 |
Resistant |
| ENSG00000267787.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.019323566 |
Resistant |
| ENSG00000267919.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035759189 |
Resistant |
| ENSG00000270141.2 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013708003 |
Resistant |
| ENSG00000270237.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031887933 |
Resistant |
| ENSG00000271265.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.014357321 |
Resistant |
| ENSG00000272368.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042103183 |
Resistant |
| ENSG00000272452.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046152855 |
Resistant |
| ENSG00000272764.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017961911 |
Resistant |
| ENSG00000272914.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031779093 |
Resistant |
| ENSG00000273307.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030211751 |
Resistant |
| ENSG00000203325.3 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.045441377 |
Resistant |
| ENSG00000204929.7 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.04132026 |
Resistant |
| ENSG00000205041.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.004019377 |
Resistant |
| ENSG00000224077.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.040478811 |
Resistant |
| ENSG00000224969.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.040509758 |
Resistant |
| ENSG00000225857.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.047700051 |
Resistant |
| ENSG00000225914.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.005205238 |
Resistant |
| ENSG00000226179.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.02505093 |
Resistant |
| ENSG00000227218.3 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.038478399 |
Resistant |
| ENSG00000228389.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.021826276 |
Resistant |
| ENSG00000230337.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.003332402 |
Resistant |
| ENSG00000230433.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.007923689 |
Resistant |
| ENSG00000230943.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.007041367 |
Resistant |
| ENSG00000232093.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.01977818 |
Resistant |
| ENSG00000232139.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.033514752 |
Resistant |
| ENSG00000232754.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.034025752 |
Resistant |
| ENSG00000234155.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.002845958 |
Resistant |
| ENSG00000235119.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.003594673 |
Resistant |
| ENSG00000235358.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.026304268 |
Resistant |
| ENSG00000235560.3 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.034205874 |
Resistant |
| ENSG00000236581.4 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.024624604 |
Resistant |
| ENSG00000237943.2 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.015688779 |
Resistant |
| ENSG00000244268.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.030384092 |
Resistant |
| ENSG00000246859.2 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.046322654 |
Resistant |
| ENSG00000247679.2 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.033845218 |
Resistant |
| ENSG00000249532.2 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.007542171 |
Resistant |
| ENSG00000249695.2 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.041713928 |
Resistant |
| ENSG00000250994.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.040156634 |
Resistant |
| ENSG00000254397.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.040671238 |
Resistant |
| ENSG00000260083.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.045983359 |
Resistant |
| ENSG00000260209.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.033801195 |
Resistant |
| ENSG00000260394.2 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.039927073 |
Resistant |
| ENSG00000263080.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.010423909 |
Resistant |
| ENSG00000266933.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.01639726 |
Resistant |
| ENSG00000266942.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.021160093 |
Resistant |
| ENSG00000269534.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.048606973 |
Resistant |
| ENSG00000269737.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.043739666 |
Resistant |
| ENSG00000272795.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.031514615 |
Resistant |
| ENSG00000273001.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.048407968 |
Resistant |
| ENSG00000164621.5 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048952033 |
Resistant |
| ENSG00000187904.3 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042346521 |
Resistant |
| ENSG00000188206.5 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006862143 |
Resistant |
| ENSG00000203739.3 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049902938 |
Resistant |
| ENSG00000205959.3 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015950502 |
Resistant |
| ENSG00000214347.5 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021391778 |
Resistant |
| ENSG00000214432.5 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042026813 |
Resistant |
| ENSG00000215863.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019438491 |
Resistant |
| ENSG00000223380.3 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009718449 |
Resistant |
| ENSG00000223462.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034151452 |
Resistant |
| ENSG00000223804.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026798815 |
Resistant |
| ENSG00000224032.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039362947 |
Resistant |
| ENSG00000224043.3 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021718125 |
Resistant |
| ENSG00000224138.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043800454 |
Resistant |
| ENSG00000225518.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024075045 |
Resistant |
| ENSG00000225981.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0328975 |
Resistant |
| ENSG00000226067.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041284561 |
Resistant |
| ENSG00000226637.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028842743 |
Resistant |
| ENSG00000226816.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03519298 |
Resistant |
| ENSG00000227733.4 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009261114 |
Resistant |
| ENSG00000228022.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043175709 |
Resistant |
| ENSG00000228150.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000948746 |
Resistant |
| ENSG00000232677.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028295736 |
Resistant |
| ENSG00000232788.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006943226 |
Resistant |
| ENSG00000234741.3 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001610671 |
Resistant |
| ENSG00000235185.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042225137 |
Resistant |
| ENSG00000235296.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045859827 |
Resistant |
| ENSG00000235398.4 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001390805 |
Resistant |
| ENSG00000235999.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030508108 |
Resistant |
| ENSG00000236115.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01260554 |
Resistant |
| ENSG00000236869.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007606173 |
Resistant |
| ENSG00000236943.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004368321 |
Resistant |
| ENSG00000237133.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014228462 |
Resistant |
| ENSG00000237343.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03797624 |
Resistant |
| ENSG00000237402.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03245631 |
Resistant |
| ENSG00000237438.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009729266 |
Resistant |
| ENSG00000237756.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049645436 |
Resistant |
| ENSG00000239480.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029474331 |
Resistant |
| ENSG00000242474.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023167994 |
Resistant |
| ENSG00000243069.3 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044662201 |
Resistant |
| ENSG00000247708.3 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036002286 |
Resistant |
| ENSG00000248356.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020021745 |
Resistant |
| ENSG00000248508.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043479065 |
Resistant |
| ENSG00000250156.3 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036703595 |
Resistant |
| ENSG00000251409.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030651243 |
Resistant |
| ENSG00000251603.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038789601 |
Resistant |
| ENSG00000253917.3 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015543045 |
Resistant |
| ENSG00000254370.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029295994 |
Resistant |
| ENSG00000254703.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005485358 |
Resistant |
| ENSG00000255651.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038207747 |
Resistant |
| ENSG00000255867.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011533061 |
Resistant |
| ENSG00000257151.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045976588 |
Resistant |
| ENSG00000257913.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017600785 |
Resistant |
| ENSG00000259206.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017476618 |
Resistant |
| ENSG00000259238.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038668016 |
Resistant |
| ENSG00000259274.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044081503 |
Resistant |
| ENSG00000259310.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009036997 |
Resistant |
| ENSG00000259343.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007279599 |
Resistant |
| ENSG00000259416.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004220133 |
Resistant |
| ENSG00000260038.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021269428 |
Resistant |
| ENSG00000260185.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016000219 |
Resistant |
| ENSG00000260306.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021847964 |
Resistant |
| ENSG00000260534.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005503375 |
Resistant |
| ENSG00000260643.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036371955 |
Resistant |
| ENSG00000260905.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029011167 |
Resistant |
| ENSG00000261095.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040395029 |
Resistant |
| ENSG00000261114.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015283699 |
Resistant |
| ENSG00000261141.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047964229 |
Resistant |
| ENSG00000261270.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023760743 |
Resistant |
| ENSG00000261291.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026872451 |
Resistant |
| ENSG00000261430.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040056985 |
Resistant |
| ENSG00000261468.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016750941 |
Resistant |
| ENSG00000261646.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040686884 |
Resistant |
| ENSG00000261780.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01805838 |
Resistant |
| ENSG00000265688.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038864892 |
Resistant |
| ENSG00000266079.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043294388 |
Resistant |
| ENSG00000266654.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035372633 |
Resistant |
| ENSG00000266978.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027574525 |
Resistant |
| ENSG00000267939.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049935078 |
Resistant |
| ENSG00000268471.3 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011991507 |
Resistant |
| ENSG00000269161.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029523262 |
Resistant |
| ENSG00000269893.2 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00115653 |
Resistant |
| ENSG00000270084.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00086339 |
Resistant |
| ENSG00000270164.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042635161 |
Resistant |
| ENSG00000270750.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049534166 |
Resistant |
| ENSG00000270761.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031859388 |
Resistant |
| ENSG00000271722.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005198631 |
Resistant |
| ENSG00000272077.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019661821 |
Resistant |
| ENSG00000272274.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030078566 |
Resistant |
| ENSG00000272335.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005039633 |
Resistant |
| ENSG00000272365.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030028866 |
Resistant |
| ENSG00000272369.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039926977 |
Resistant |
| ENSG00000272379.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033683034 |
Resistant |
| ENSG00000272416.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028664166 |
Resistant |
| ENSG00000272744.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024844496 |
Resistant |
| ENSG00000272755.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002518161 |
Resistant |
| ENSG00000273058.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008525047 |
Resistant |
| ENSG00000273059.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012888644 |
Resistant |
| ENSG00000273075.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02018808 |
Resistant |
| ENSG00000273131.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011853758 |
Resistant |
| ENSG00000273203.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016496475 |
Resistant |
| ENSG00000273237.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022895255 |
Resistant |
| ENSG00000273289.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01181461 |
Resistant |
| ENSG00000204362.5 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.037784621 |
Resistant |
| ENSG00000229491.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.020879663 |
Resistant |
| ENSG00000246422.2 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.038900562 |
Resistant |
| ENSG00000259921.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.029340415 |
Resistant |
| ENSG00000269194.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.013138358 |
Resistant |
| ENSG00000271856.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.028537727 |
Resistant |
| ENSG00000177757.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.025191896 |
Resistant |
| ENSG00000182586.3 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.011979672 |
Resistant |
| ENSG00000215447.3 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.039606126 |
Resistant |
| ENSG00000223473.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.034369434 |
Resistant |
| ENSG00000223477.3 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.010218722 |
Resistant |
| ENSG00000223745.3 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.022358544 |
Resistant |
| ENSG00000223768.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.044045036 |
Resistant |
| ENSG00000225037.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.042801605 |
Resistant |
| ENSG00000225793.2 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.047740654 |
Resistant |
| ENSG00000226200.2 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.005099372 |
Resistant |
| ENSG00000227372.6 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.042087176 |
Resistant |
| ENSG00000227431.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.023412791 |
Resistant |
| ENSG00000228150.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.014847011 |
Resistant |
| ENSG00000228544.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.03291937 |
Resistant |
| ENSG00000229431.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.037666887 |
Resistant |
| ENSG00000230068.2 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.021570543 |
Resistant |
| ENSG00000230826.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.010166443 |
Resistant |
| ENSG00000232098.2 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.012654779 |
Resistant |
| ENSG00000232124.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.039027714 |
Resistant |
| ENSG00000232160.2 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.024238216 |
Resistant |
| ENSG00000233330.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.045356358 |
Resistant |
| ENSG00000233799.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.027068071 |
Resistant |
| ENSG00000235092.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.013693714 |
Resistant |
| ENSG00000235477.2 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.039956827 |
Resistant |
| ENSG00000235806.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.035471599 |
Resistant |
| ENSG00000235927.2 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.024674139 |
Resistant |
| ENSG00000236869.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.004549877 |
Resistant |
| ENSG00000237298.4 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.027113894 |
Resistant |
| ENSG00000240057.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.039497192 |
Resistant |
| ENSG00000240453.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.024879982 |
Resistant |
| ENSG00000240996.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.005746517 |
Resistant |
| ENSG00000243243.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.039909309 |
Resistant |
| ENSG00000245573.3 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.017582636 |
Resistant |
| ENSG00000247373.2 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.03366871 |
Resistant |
| ENSG00000247572.3 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.04501911 |
Resistant |
| ENSG00000249348.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.016572612 |
Resistant |
| ENSG00000249602.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.048843466 |
Resistant |
| ENSG00000250326.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.011368742 |
Resistant |
| ENSG00000251141.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.048834209 |
Resistant |
| ENSG00000251555.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.001348897 |
Resistant |
| ENSG00000253559.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.030699147 |
Resistant |
| ENSG00000253744.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.042888303 |
Resistant |
| ENSG00000255164.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.045246715 |
Resistant |
| ENSG00000255455.2 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.02287793 |
Resistant |
| ENSG00000255847.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.011298537 |
Resistant |
| ENSG00000255992.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.025452817 |
Resistant |
| ENSG00000257337.2 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.046167694 |
Resistant |
| ENSG00000257410.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.022219557 |
Resistant |
| ENSG00000257497.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.020151146 |
Resistant |
| ENSG00000259319.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.040232794 |
Resistant |
| ENSG00000259656.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.027459044 |
Resistant |
| ENSG00000260091.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.032292299 |
Resistant |
| ENSG00000260276.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.049877755 |
Resistant |
| ENSG00000260528.2 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.044253136 |
Resistant |
| ENSG00000260743.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.02222717 |
Resistant |
| ENSG00000260874.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.040452041 |
Resistant |
| ENSG00000261101.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.020068943 |
Resistant |
| ENSG00000261187.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.033255793 |
Resistant |
| ENSG00000261512.2 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.037025671 |
Resistant |
| ENSG00000261766.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.017722816 |
Resistant |
| ENSG00000262412.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.034790152 |
Resistant |
| ENSG00000265205.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.011768596 |
Resistant |
| ENSG00000265943.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.021888576 |
Resistant |
| ENSG00000266053.2 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.01298535 |
Resistant |
| ENSG00000266120.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.041525707 |
Resistant |
| ENSG00000267035.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.014328815 |
Resistant |
| ENSG00000268543.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.029539552 |
Resistant |
| ENSG00000268912.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.029836284 |
Resistant |
| ENSG00000269737.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.01737216 |
Resistant |
| ENSG00000270012.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.001130643 |
Resistant |
| ENSG00000270050.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.041909961 |
Resistant |
| ENSG00000270067.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.004682744 |
Resistant |
| ENSG00000270949.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.035021749 |
Resistant |
| ENSG00000271992.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.039950119 |
Resistant |
| ENSG00000272077.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.026876954 |
Resistant |
| ENSG00000272631.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.02576677 |
Resistant |
| ENSG00000272931.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.047427032 |
Resistant |
| ENSG00000273295.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.036372974 |
Resistant |
| ENSG00000168367.5 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.045688144 |
Resistant |
| ENSG00000184274.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.037176859 |
Resistant |
| ENSG00000186594.8 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.020872845 |
Resistant |
| ENSG00000189149.7 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.016893728 |
Resistant |
| ENSG00000203325.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.031880482 |
Resistant |
| ENSG00000204011.4 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.006082196 |
Resistant |
| ENSG00000205885.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.030642795 |
Resistant |
| ENSG00000214353.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.015902572 |
Resistant |
| ENSG00000214407.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.033762002 |
Resistant |
| ENSG00000214894.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.006396139 |
Resistant |
| ENSG00000214922.5 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.03604307 |
Resistant |
| ENSG00000215068.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.008831498 |
Resistant |
| ENSG00000215863.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.004147812 |
Resistant |
| ENSG00000222032.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.015511451 |
Resistant |
| ENSG00000223390.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.039941625 |
Resistant |
| ENSG00000223396.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.042663154 |
Resistant |
| ENSG00000223401.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.019260076 |
Resistant |
| ENSG00000223477.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.032413474 |
Resistant |
| ENSG00000223511.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.035536102 |
Resistant |
| ENSG00000223711.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.048802639 |
Resistant |
| ENSG00000223759.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.024077874 |
Resistant |
| ENSG00000223774.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.035083148 |
Resistant |
| ENSG00000223779.4 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.025630641 |
Resistant |
| ENSG00000223804.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.0011476 |
Resistant |
| ENSG00000223855.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.034166651 |
Resistant |
| ENSG00000224034.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.047000341 |
Resistant |
| ENSG00000224138.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.047838296 |
Resistant |
| ENSG00000224409.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.041159371 |
Resistant |
| ENSG00000224413.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.000706141 |
Resistant |
| ENSG00000224468.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.003548389 |
Resistant |
| ENSG00000224481.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.047783156 |
Resistant |
| ENSG00000224959.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.003825413 |
Resistant |
| ENSG00000225075.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.047313901 |
Resistant |
| ENSG00000225541.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.0435114 |
Resistant |
| ENSG00000225643.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.004346644 |
Resistant |
| ENSG00000225778.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.021404778 |
Resistant |
| ENSG00000225981.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.03288501 |
Resistant |
| ENSG00000226026.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.017833366 |
Resistant |
| ENSG00000226380.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.023488184 |
Resistant |
| ENSG00000226445.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.021000919 |
Resistant |
| ENSG00000226520.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.012445998 |
Resistant |
| ENSG00000226637.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.011918096 |
Resistant |
| ENSG00000227014.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.018411583 |
Resistant |
| ENSG00000227076.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.021603094 |
Resistant |
| ENSG00000227200.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.042192682 |
Resistant |
| ENSG00000227477.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.026932435 |
Resistant |
| ENSG00000227496.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.005134385 |
Resistant |
| ENSG00000227706.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.032957932 |
Resistant |
| ENSG00000227741.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.030774725 |
Resistant |
| ENSG00000227959.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.012416854 |
Resistant |
| ENSG00000228022.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.030775966 |
Resistant |
| ENSG00000228028.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.029772425 |
Resistant |
| ENSG00000228060.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.040839269 |
Resistant |
| ENSG00000228237.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.002139172 |
Resistant |
| ENSG00000228857.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.033604974 |
Resistant |
| ENSG00000229036.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.000328857 |
Resistant |
| ENSG00000229512.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.00061936 |
Resistant |
| ENSG00000229801.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.027087668 |
Resistant |
| ENSG00000229847.4 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.03551118 |
Resistant |
| ENSG00000229867.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.020640903 |
Resistant |
| ENSG00000229915.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.016647507 |
Resistant |
| ENSG00000229950.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.046817999 |
Resistant |
| ENSG00000229951.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.00047234 |
Resistant |
| ENSG00000230300.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.036450167 |
Resistant |
| ENSG00000230499.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.014457847 |
Resistant |
| ENSG00000231187.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.00403998 |
Resistant |
| ENSG00000231521.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.008734775 |
Resistant |
| ENSG00000231652.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.007091161 |
Resistant |
| ENSG00000231734.4 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.006373128 |
Resistant |
| ENSG00000231811.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.020803245 |
Resistant |
| ENSG00000231858.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.041800591 |
Resistant |
| ENSG00000232043.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.046460032 |
Resistant |
| ENSG00000232194.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.021883091 |
Resistant |
| ENSG00000232415.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.043370551 |
Resistant |
| ENSG00000232719.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.047402136 |
Resistant |
| ENSG00000232725.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.00027185 |
Resistant |
| ENSG00000232788.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.01772007 |
Resistant |
| ENSG00000232855.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.013215384 |
Resistant |
| ENSG00000232913.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.042119454 |
Resistant |
| ENSG00000233058.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.039393143 |
Resistant |
| ENSG00000233081.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.00166426 |
Resistant |
| ENSG00000233368.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.010900907 |
Resistant |
| ENSG00000233429.5 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.043140865 |
Resistant |
| ENSG00000233559.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.033567548 |
Resistant |
| ENSG00000233621.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.015440028 |
Resistant |
| ENSG00000233817.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.017141116 |
Resistant |
| ENSG00000233818.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.035788102 |
Resistant |
| ENSG00000233845.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.000622625 |
Resistant |
| ENSG00000234199.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.023492302 |
Resistant |
| ENSG00000234264.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.03391202 |
Resistant |
| ENSG00000234290.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.006092768 |
Resistant |
| ENSG00000234362.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.035934124 |
Resistant |
| ENSG00000234393.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.027730559 |
Resistant |
| ENSG00000234459.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.012713612 |
Resistant |
| ENSG00000235027.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.001842441 |
Resistant |
| ENSG00000235204.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.000126718 |
Resistant |
| ENSG00000235398.4 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.021073582 |
Resistant |
| ENSG00000235427.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.040296065 |
Resistant |
| ENSG00000235527.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.022712305 |
Resistant |
| ENSG00000235565.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.0443599 |
Resistant |
| ENSG00000235790.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.006909815 |
Resistant |
| ENSG00000235927.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.015355715 |
Resistant |
| ENSG00000236065.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.024028306 |
Resistant |
| ENSG00000236383.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.002939152 |
Resistant |
| ENSG00000236390.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.03177585 |
Resistant |
| ENSG00000236591.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.024429346 |
Resistant |
| ENSG00000236651.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.003173382 |
Resistant |
| ENSG00000236936.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.026181804 |
Resistant |
| ENSG00000236943.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.022187833 |
Resistant |
| ENSG00000237181.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.020465461 |
Resistant |
| ENSG00000237187.4 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.04875876 |
Resistant |
| ENSG00000237234.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.042793126 |
Resistant |
| ENSG00000237371.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.009589677 |
Resistant |
| ENSG00000237424.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.016342991 |
Resistant |
| ENSG00000237499.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.018761596 |
Resistant |
| ENSG00000237738.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.036496333 |
Resistant |
| ENSG00000237803.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.033231315 |
Resistant |
| ENSG00000237807.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.030754107 |
Resistant |
| ENSG00000238005.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.014010944 |
Resistant |
| ENSG00000238160.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.045297086 |
Resistant |
| ENSG00000240063.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.038701973 |
Resistant |
| ENSG00000240350.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.012465326 |
Resistant |
| ENSG00000240990.5 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.008547501 |
Resistant |
| ENSG00000241014.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.023353794 |
Resistant |
| ENSG00000241280.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.027528938 |
Resistant |
| ENSG00000241313.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.002592668 |
Resistant |
| ENSG00000241316.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.021032372 |
Resistant |
| ENSG00000243797.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.018665236 |
Resistant |
| ENSG00000244063.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.001307088 |
Resistant |
| ENSG00000244161.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.017033814 |
Resistant |
| ENSG00000244203.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.043443007 |
Resistant |
| ENSG00000244578.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.012783524 |
Resistant |
| ENSG00000244586.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.0200458 |
Resistant |
| ENSG00000245060.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.002830723 |
Resistant |
| ENSG00000245293.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.033617328 |
Resistant |
| ENSG00000245532.4 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.034587677 |
Resistant |
| ENSG00000245571.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.014924244 |
Resistant |
| ENSG00000246331.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.005071637 |
Resistant |
| ENSG00000246898.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.024340243 |
Resistant |
| ENSG00000247774.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.001607855 |
Resistant |
| ENSG00000248100.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.017553358 |
Resistant |
| ENSG00000248202.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.02389966 |
Resistant |
| ENSG00000248223.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.00924283 |
Resistant |
| ENSG00000248388.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.015954866 |
Resistant |
| ENSG00000248677.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.000831044 |
Resistant |
| ENSG00000248693.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.028783073 |
Resistant |
| ENSG00000249035.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.042333927 |
Resistant |
| ENSG00000249241.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.010845654 |
Resistant |
| ENSG00000249249.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.002721187 |
Resistant |
| ENSG00000249738.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.046628371 |
Resistant |
| ENSG00000249740.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.005325827 |
Resistant |
| ENSG00000250303.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.034852374 |
Resistant |
| ENSG00000250548.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.003624458 |
Resistant |
| ENSG00000250635.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.001327633 |
Resistant |
| ENSG00000250657.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.044079221 |
Resistant |
| ENSG00000250659.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.011451785 |
Resistant |
| ENSG00000251003.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.004964225 |
Resistant |
| ENSG00000251085.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.017997703 |
Resistant |
| ENSG00000251131.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.015076127 |
Resistant |
| ENSG00000251151.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.007384251 |
Resistant |
| ENSG00000251179.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.007421385 |
Resistant |
| ENSG00000251194.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.043095374 |
Resistant |
| ENSG00000251314.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.039228323 |
Resistant |
| ENSG00000251387.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.017122191 |
Resistant |
| ENSG00000251442.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.045280865 |
Resistant |
| ENSG00000253210.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.033891628 |
Resistant |
| ENSG00000253227.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.047268318 |
Resistant |
| ENSG00000253374.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.018821059 |
Resistant |
| ENSG00000253395.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.027029857 |
Resistant |
| ENSG00000253414.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.046894579 |
Resistant |
| ENSG00000253508.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.008117412 |
Resistant |
| ENSG00000253616.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.0000713 |
Resistant |
| ENSG00000253708.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.016301936 |
Resistant |
| ENSG00000253837.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.008410766 |
Resistant |
| ENSG00000254057.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.002228672 |
Resistant |
| ENSG00000254204.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.02953715 |
Resistant |
| ENSG00000254363.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.010224521 |
Resistant |
| ENSG00000254639.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.010219842 |
Resistant |
| ENSG00000254847.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.00840659 |
Resistant |
| ENSG00000255197.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.025751657 |
Resistant |
| ENSG00000255322.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.004498739 |
Resistant |
| ENSG00000255355.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.023027806 |
Resistant |
| ENSG00000255364.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.04517068 |
Resistant |
| ENSG00000255509.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.046758015 |
Resistant |
| ENSG00000255557.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.021300853 |
Resistant |
| ENSG00000256006.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.013723606 |
Resistant |
| ENSG00000256050.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.009338632 |
Resistant |
| ENSG00000256128.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.02727064 |
Resistant |
| ENSG00000256894.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.011781138 |
Resistant |
| ENSG00000256967.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.007555591 |
Resistant |
| ENSG00000257219.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.043617017 |
Resistant |
| ENSG00000257221.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.020344819 |
Resistant |
| ENSG00000257433.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.041544979 |
Resistant |
| ENSG00000257642.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.034526581 |
Resistant |
| ENSG00000257732.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.040309806 |
Resistant |
| ENSG00000257735.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.020375712 |
Resistant |
| ENSG00000258048.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.034524775 |
Resistant |
| ENSG00000258086.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.02248727 |
Resistant |
| ENSG00000258096.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.047566797 |
Resistant |
| ENSG00000258602.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.0281028 |
Resistant |
| ENSG00000258646.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.008016148 |
Resistant |
| ENSG00000258667.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.01567486 |
Resistant |
| ENSG00000258711.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.029206876 |
Resistant |
| ENSG00000258733.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.009200057 |
Resistant |
| ENSG00000258808.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.01792563 |
Resistant |
| ENSG00000258929.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.0000956 |
Resistant |
| ENSG00000259062.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.017504533 |
Resistant |
| ENSG00000259125.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.014705991 |
Resistant |
| ENSG00000259146.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.028016345 |
Resistant |
| ENSG00000259417.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.043068199 |
Resistant |
| ENSG00000259523.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.030699222 |
Resistant |
| ENSG00000259712.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.027828443 |
Resistant |
| ENSG00000259782.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.045972083 |
Resistant |
| ENSG00000259807.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.018805129 |
Resistant |
| ENSG00000259863.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.047307885 |
Resistant |
| ENSG00000259867.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.024660278 |
Resistant |
| ENSG00000260021.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.031402957 |
Resistant |
| ENSG00000260065.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.017208256 |
Resistant |
| ENSG00000260336.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.000734764 |
Resistant |
| ENSG00000260604.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.03168996 |
Resistant |
| ENSG00000260660.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.044282497 |
Resistant |
| ENSG00000260693.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.003933186 |
Resistant |
| ENSG00000260833.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.038344642 |
Resistant |
| ENSG00000260841.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.03205465 |
Resistant |
| ENSG00000260910.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.023888127 |
Resistant |
| ENSG00000261039.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.017587714 |
Resistant |
| ENSG00000261055.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.015048493 |
Resistant |
| ENSG00000261064.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.0305495 |
Resistant |
| ENSG00000261270.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.019126822 |
Resistant |
| ENSG00000261334.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.039914786 |
Resistant |
| ENSG00000261512.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.012894262 |
Resistant |
| ENSG00000261616.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.038876776 |
Resistant |
| ENSG00000261618.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.044035913 |
Resistant |
| ENSG00000261690.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.006485331 |
Resistant |
| ENSG00000261801.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.011923082 |
Resistant |
| ENSG00000262115.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.022982924 |
Resistant |
| ENSG00000262136.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.012380303 |
Resistant |
| ENSG00000262188.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.026594079 |
Resistant |
| ENSG00000262903.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.022252643 |
Resistant |
| ENSG00000262905.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.001609428 |
Resistant |
| ENSG00000262979.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.046311138 |
Resistant |
| ENSG00000263105.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.004998748 |
Resistant |
| ENSG00000263176.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.022544851 |
Resistant |
| ENSG00000264339.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.023791069 |
Resistant |
| ENSG00000264448.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.004324901 |
Resistant |
| ENSG00000265445.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.03801875 |
Resistant |
| ENSG00000265490.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.044529077 |
Resistant |
| ENSG00000265766.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.017801593 |
Resistant |
| ENSG00000266401.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.021562283 |
Resistant |
| ENSG00000266498.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.046036801 |
Resistant |
| ENSG00000266900.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.036445145 |
Resistant |
| ENSG00000266903.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.006128456 |
Resistant |
| ENSG00000266947.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.002628209 |
Resistant |
| ENSG00000267052.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.045563514 |
Resistant |
| ENSG00000267201.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.0011418 |
Resistant |
| ENSG00000267375.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.014338181 |
Resistant |
| ENSG00000267416.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.049254469 |
Resistant |
| ENSG00000267519.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.00493662 |
Resistant |
| ENSG00000267530.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.045383681 |
Resistant |
| ENSG00000267644.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.042528187 |
Resistant |
| ENSG00000267677.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.039503343 |
Resistant |
| ENSG00000267874.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.024768729 |
Resistant |
| ENSG00000268199.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.034909531 |
Resistant |
| ENSG00000268549.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.037044127 |
Resistant |
| ENSG00000268746.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.001432822 |
Resistant |
| ENSG00000268812.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.010783191 |
Resistant |
| ENSG00000269019.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.024086528 |
Resistant |
| ENSG00000269202.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.045049127 |
Resistant |
| ENSG00000269439.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.036585421 |
Resistant |
| ENSG00000269899.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.01512747 |
Resistant |
| ENSG00000269902.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.023168131 |
Resistant |
| ENSG00000269967.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.0035733 |
Resistant |
| ENSG00000269976.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.021340629 |
Resistant |
| ENSG00000270031.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.006131546 |
Resistant |
| ENSG00000270040.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.028874012 |
Resistant |
| ENSG00000270069.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.046159361 |
Resistant |
| ENSG00000270116.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.024812 |
Resistant |
| ENSG00000270190.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.014102295 |
Resistant |
| ENSG00000270210.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.043613744 |
Resistant |
| ENSG00000270346.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.027247271 |
Resistant |
| ENSG00000270640.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.009217952 |
Resistant |
| ENSG00000270760.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.035387556 |
Resistant |
| ENSG00000271204.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.010332672 |
Resistant |
| ENSG00000271590.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.008898343 |
Resistant |
| ENSG00000271646.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.000413013 |
Resistant |
| ENSG00000271709.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.015944728 |
Resistant |
| ENSG00000271811.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.022767551 |
Resistant |
| ENSG00000271857.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.001566696 |
Resistant |
| ENSG00000271921.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.015152152 |
Resistant |
| ENSG00000272094.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.048390358 |
Resistant |
| ENSG00000272142.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.003814419 |
Resistant |
| ENSG00000272144.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.026065515 |
Resistant |
| ENSG00000272221.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.021432058 |
Resistant |
| ENSG00000272235.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.030565365 |
Resistant |
| ENSG00000272255.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.002276844 |
Resistant |
| ENSG00000272282.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.015182029 |
Resistant |
| ENSG00000272361.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.039337544 |
Resistant |
| ENSG00000272473.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.049957839 |
Resistant |
| ENSG00000272666.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.017192008 |
Resistant |
| ENSG00000272668.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.015316367 |
Resistant |
| ENSG00000272702.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.023592435 |
Resistant |
| ENSG00000272709.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.039514958 |
Resistant |
| ENSG00000272734.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.022289647 |
Resistant |
| ENSG00000272755.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.006715737 |
Resistant |
| ENSG00000272760.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.002073316 |
Resistant |
| ENSG00000272761.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.015971126 |
Resistant |
| ENSG00000272782.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.026835151 |
Resistant |
| ENSG00000272796.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.035609875 |
Resistant |
| ENSG00000272913.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.003100144 |
Resistant |
| ENSG00000272949.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.008612905 |
Resistant |
| ENSG00000272950.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.002432447 |
Resistant |
| ENSG00000273065.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.003542085 |
Resistant |
| ENSG00000273123.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.021225167 |
Resistant |
| ENSG00000273143.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.01561289 |
Resistant |
| ENSG00000273174.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.007029141 |
Resistant |
| ENSG00000273186.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.006770431 |
Resistant |
| ENSG00000273193.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.018711896 |
Resistant |
| ENSG00000273248.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.047918164 |
Resistant |
| ENSG00000273305.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.00244265 |
Resistant |
| ENSG00000273319.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.010642385 |
Resistant |
| ENSG00000273368.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.003128442 |
Resistant |
| ENSG00000214407.3 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.031328303 |
Resistant |
| ENSG00000225506.2 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.024414551 |
Resistant |
| ENSG00000227591.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.04007366 |
Resistant |
| ENSG00000229056.2 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.02174176 |
Resistant |
| ENSG00000232324.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.044187517 |
Resistant |
| ENSG00000235091.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.022169236 |
Resistant |
| ENSG00000236305.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.02759815 |
Resistant |
| ENSG00000237813.3 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.0095591 |
Resistant |
| ENSG00000238120.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.017489862 |
Resistant |
| ENSG00000241280.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.013224085 |
Resistant |
| ENSG00000244128.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.014689111 |
Resistant |
| ENSG00000247317.3 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.002694691 |
Resistant |
| ENSG00000254286.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.011051353 |
Resistant |
| ENSG00000255343.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.013638555 |
Resistant |
| ENSG00000257391.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.044813531 |
Resistant |
| ENSG00000257556.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.01089032 |
Resistant |
| ENSG00000258303.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.042518385 |
Resistant |
| ENSG00000266313.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.032346092 |
Resistant |
| ENSG00000267547.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.045523967 |
Resistant |
| ENSG00000273341.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.028912072 |
Resistant |
| ENSG00000177337.3 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.001580134 |
Resistant |
| ENSG00000185168.5 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.043619571 |
Resistant |
| ENSG00000189238.4 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.031325801 |
Resistant |
| ENSG00000196566.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.001520917 |
Resistant |
| ENSG00000203593.3 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.031766915 |
Resistant |
| ENSG00000204054.7 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.002369682 |
Resistant |
| ENSG00000215808.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.022272352 |
Resistant |
| ENSG00000215863.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.001863017 |
Resistant |
| ENSG00000222043.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.004227921 |
Resistant |
| ENSG00000223404.3 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.031089548 |
Resistant |
| ENSG00000223414.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.043399625 |
Resistant |
| ENSG00000223475.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.048484437 |
Resistant |
| ENSG00000223542.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.041949724 |
Resistant |
| ENSG00000223586.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.022970412 |
Resistant |
| ENSG00000223608.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.024058507 |
Resistant |
| ENSG00000223759.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.000664794 |
Resistant |
| ENSG00000224460.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.022154373 |
Resistant |
| ENSG00000224817.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.021888546 |
Resistant |
| ENSG00000224822.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.046007313 |
Resistant |
| ENSG00000224846.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.015738524 |
Resistant |
| ENSG00000225039.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.017932026 |
Resistant |
| ENSG00000226067.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.002019684 |
Resistant |
| ENSG00000226519.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.002061638 |
Resistant |
| ENSG00000226659.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.023063154 |
Resistant |
| ENSG00000227117.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.028299461 |
Resistant |
| ENSG00000227240.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.048240941 |
Resistant |
| ENSG00000227355.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.018483342 |
Resistant |
| ENSG00000227533.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.037545096 |
Resistant |
| ENSG00000227674.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.043026597 |
Resistant |
| ENSG00000227711.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.019560499 |
Resistant |
| ENSG00000227769.3 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.043262686 |
Resistant |
| ENSG00000227932.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.045010923 |
Resistant |
| ENSG00000227954.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.003714102 |
Resistant |
| ENSG00000228150.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.00906806 |
Resistant |
| ENSG00000228404.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.016716792 |
Resistant |
| ENSG00000228412.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.007592899 |
Resistant |
| ENSG00000228649.4 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.017738137 |
Resistant |
| ENSG00000228680.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.033645998 |
Resistant |
| ENSG00000229967.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.007823784 |
Resistant |
| ENSG00000230176.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.048900373 |
Resistant |
| ENSG00000230615.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.033591422 |
Resistant |
| ENSG00000230731.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.011727464 |
Resistant |
| ENSG00000230826.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.003537371 |
Resistant |
| ENSG00000231249.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.009812749 |
Resistant |
| ENSG00000231310.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.039022555 |
Resistant |
| ENSG00000231551.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.008653862 |
Resistant |
| ENSG00000231646.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.015418054 |
Resistant |
| ENSG00000231742.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.024107527 |
Resistant |
| ENSG00000231858.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.043300959 |
Resistant |
| ENSG00000232290.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.027825726 |
Resistant |
| ENSG00000232490.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.007680238 |
Resistant |
| ENSG00000232533.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.018044447 |
Resistant |
| ENSG00000232618.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.020236383 |
Resistant |
| ENSG00000232692.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.022851919 |
Resistant |
| ENSG00000232693.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.01470685 |
Resistant |
| ENSG00000232935.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.00897224 |
Resistant |
| ENSG00000232936.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.04924827 |
Resistant |
| ENSG00000232973.7 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.0285022 |
Resistant |
| ENSG00000233411.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.04378205 |
Resistant |
| ENSG00000233430.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.044891883 |
Resistant |
| ENSG00000233461.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.004820071 |
Resistant |
| ENSG00000233491.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.043101882 |
Resistant |
| ENSG00000233547.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.003429659 |
Resistant |
| ENSG00000233783.3 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.020450195 |
Resistant |
| ENSG00000234147.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.038104835 |
Resistant |
| ENSG00000234292.3 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.000711741 |
Resistant |
| ENSG00000234396.3 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.04213101 |
Resistant |
| ENSG00000234459.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.025799864 |
Resistant |
| ENSG00000234556.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.037723458 |
Resistant |
| ENSG00000234698.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.027825708 |
Resistant |
| ENSG00000234740.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.014774501 |
Resistant |
| ENSG00000234817.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.000343756 |
Resistant |
| ENSG00000235052.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.013812624 |
Resistant |
| ENSG00000235285.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.015949887 |
Resistant |
| ENSG00000235398.4 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.003259912 |
Resistant |
| ENSG00000235419.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.018429194 |
Resistant |
| ENSG00000235848.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.017045442 |
Resistant |
| ENSG00000235999.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.001102603 |
Resistant |
| ENSG00000236024.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.028602012 |
Resistant |
| ENSG00000236212.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.014794522 |
Resistant |
| ENSG00000236345.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.02865482 |
Resistant |
| ENSG00000236528.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.014524684 |
Resistant |
| ENSG00000236751.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.049936081 |
Resistant |
| ENSG00000236943.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.004650745 |
Resistant |
| ENSG00000237324.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.036400658 |
Resistant |
| ENSG00000237471.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.013842344 |
Resistant |
| ENSG00000237595.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.015623118 |
Resistant |
| ENSG00000237689.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.045996239 |
Resistant |
| ENSG00000239353.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.018931076 |
Resistant |
| ENSG00000240790.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.024329511 |
Resistant |
| ENSG00000240875.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.04722627 |
Resistant |
| ENSG00000241313.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.030012422 |
Resistant |
| ENSG00000241599.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.032376903 |
Resistant |
| ENSG00000242125.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.034828323 |
Resistant |
| ENSG00000243967.3 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.040259641 |
Resistant |
| ENSG00000246523.3 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.046853426 |
Resistant |
| ENSG00000246876.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.027305799 |
Resistant |
| ENSG00000247134.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.022607181 |
Resistant |
| ENSG00000247774.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.013075096 |
Resistant |
| ENSG00000248323.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.005349948 |
Resistant |
| ENSG00000248515.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.031782034 |
Resistant |
| ENSG00000248787.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.012130549 |
Resistant |
| ENSG00000249252.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.0000654 |
Resistant |
| ENSG00000249328.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.040330759 |
Resistant |
| ENSG00000249345.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.010731117 |
Resistant |
| ENSG00000249614.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.012564928 |
Resistant |
| ENSG00000249685.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.003726497 |
Resistant |
| ENSG00000249706.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.046856726 |
Resistant |
| ENSG00000249713.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.039527456 |
Resistant |
| ENSG00000249996.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.007183681 |
Resistant |
| ENSG00000250061.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.031155705 |
Resistant |
| ENSG00000250258.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.048336994 |
Resistant |
| ENSG00000250874.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.034382724 |
Resistant |
| ENSG00000251003.3 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.003296205 |
Resistant |
| ENSG00000251026.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.023990085 |
Resistant |
| ENSG00000251359.3 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.003327137 |
Resistant |
| ENSG00000251432.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.016067224 |
Resistant |
| ENSG00000251574.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.042967269 |
Resistant |
| ENSG00000251598.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.038757044 |
Resistant |
| ENSG00000251652.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.025330418 |
Resistant |
| ENSG00000253210.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.030841891 |
Resistant |
| ENSG00000253335.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.042017582 |
Resistant |
| ENSG00000253744.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.044443119 |
Resistant |
| ENSG00000254028.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.045111395 |
Resistant |
| ENSG00000254762.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.018353433 |
Resistant |
| ENSG00000254821.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.043966895 |
Resistant |
| ENSG00000255321.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.02503402 |
Resistant |
| ENSG00000255414.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.039031829 |
Resistant |
| ENSG00000255946.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.028505367 |
Resistant |
| ENSG00000255992.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.015821854 |
Resistant |
| ENSG00000256128.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.034110889 |
Resistant |
| ENSG00000256546.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.042408165 |
Resistant |
| ENSG00000257135.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.020219152 |
Resistant |
| ENSG00000257261.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.008656679 |
Resistant |
| ENSG00000257433.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.002015024 |
Resistant |
| ENSG00000257496.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.016545509 |
Resistant |
| ENSG00000257636.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.023466302 |
Resistant |
| ENSG00000257718.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.00083899 |
Resistant |
| ENSG00000257829.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.00805988 |
Resistant |
| ENSG00000258034.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.011373734 |
Resistant |
| ENSG00000258096.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.008487007 |
Resistant |
| ENSG00000258553.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.005444011 |
Resistant |
| ENSG00000259687.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.012101492 |
Resistant |
| ENSG00000259828.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.01695796 |
Resistant |
| ENSG00000260364.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.016743992 |
Resistant |
| ENSG00000260466.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.01134383 |
Resistant |
| ENSG00000260693.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.028745975 |
Resistant |
| ENSG00000260744.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.023179078 |
Resistant |
| ENSG00000260757.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.002676579 |
Resistant |
| ENSG00000260834.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.029760883 |
Resistant |
| ENSG00000260932.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.036997581 |
Resistant |
| ENSG00000261122.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.044379183 |
Resistant |
| ENSG00000261334.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.021824575 |
Resistant |
| ENSG00000261369.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.004740249 |
Resistant |
| ENSG00000261513.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.04211409 |
Resistant |
| ENSG00000261519.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.045990805 |
Resistant |
| ENSG00000261595.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.036428831 |
Resistant |
| ENSG00000261600.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.015062189 |
Resistant |
| ENSG00000261744.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.019046599 |
Resistant |
| ENSG00000261751.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.043132544 |
Resistant |
| ENSG00000261757.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.024561382 |
Resistant |
| ENSG00000261761.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.032685167 |
Resistant |
| ENSG00000262001.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.033060907 |
Resistant |
| ENSG00000262136.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.010886168 |
Resistant |
| ENSG00000262292.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.033968767 |
Resistant |
| ENSG00000262454.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.02760513 |
Resistant |
| ENSG00000263327.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.017682053 |
Resistant |
| ENSG00000264083.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.026371078 |
Resistant |
| ENSG00000264595.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.023254385 |
Resistant |
| ENSG00000265554.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.045096033 |
Resistant |
| ENSG00000265717.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.037929804 |
Resistant |
| ENSG00000266401.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.012420132 |
Resistant |
| ENSG00000266664.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.038062051 |
Resistant |
| ENSG00000266805.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.026864279 |
Resistant |
| ENSG00000266970.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.038354831 |
Resistant |
| ENSG00000267446.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.048950832 |
Resistant |
| ENSG00000267578.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.008374257 |
Resistant |
| ENSG00000267751.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.013899947 |
Resistant |
| ENSG00000268686.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.014548431 |
Resistant |
| ENSG00000269400.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.008772914 |
Resistant |
| ENSG00000270174.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.035497161 |
Resistant |
| ENSG00000270640.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.04701935 |
Resistant |
| ENSG00000271200.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.040396962 |
Resistant |
| ENSG00000271579.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.027684002 |
Resistant |
| ENSG00000271631.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.044087354 |
Resistant |
| ENSG00000271762.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.005633617 |
Resistant |
| ENSG00000271825.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.01742067 |
Resistant |
| ENSG00000272226.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.045128943 |
Resistant |
| ENSG00000272366.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.033204533 |
Resistant |
| ENSG00000272461.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.016476521 |
Resistant |
| ENSG00000272755.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.004320598 |
Resistant |
| ENSG00000272769.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.023610942 |
Resistant |
| ENSG00000272784.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.017819385 |
Resistant |
| ENSG00000272832.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.047347836 |
Resistant |
| ENSG00000273129.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.043629831 |
Resistant |
| ENSG00000273160.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.048074245 |
Resistant |
| ENSG00000273209.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.043037984 |
Resistant |
| ENSG00000273481.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.001281267 |
Resistant |
| ENSG00000157306.10 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036600116 |
Resistant |
| ENSG00000173867.8 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036993426 |
Resistant |
| ENSG00000180712.3 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02050831 |
Resistant |
| ENSG00000215039.2 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034204384 |
Resistant |
| ENSG00000223960.2 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016995058 |
Resistant |
| ENSG00000224078.8 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044856939 |
Resistant |
| ENSG00000224660.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04392646 |
Resistant |
| ENSG00000224888.3 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044772575 |
Resistant |
| ENSG00000224945.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042034305 |
Resistant |
| ENSG00000224950.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035957766 |
Resistant |
| ENSG00000224975.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041043959 |
Resistant |
| ENSG00000226287.3 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027751479 |
Resistant |
| ENSG00000227116.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044015022 |
Resistant |
| ENSG00000227543.3 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03143442 |
Resistant |
| ENSG00000228509.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045282637 |
Resistant |
| ENSG00000229487.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.010124929 |
Resistant |
| ENSG00000231185.2 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028172634 |
Resistant |
| ENSG00000231851.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045056694 |
Resistant |
| ENSG00000232300.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01923939 |
Resistant |
| ENSG00000233223.2 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032400613 |
Resistant |
| ENSG00000234817.2 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043809911 |
Resistant |
| ENSG00000235244.3 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042950426 |
Resistant |
| ENSG00000235445.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029093317 |
Resistant |
| ENSG00000235481.2 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039898092 |
Resistant |
| ENSG00000236526.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049310484 |
Resistant |
| ENSG00000237517.4 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016763637 |
Resistant |
| ENSG00000237718.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040139808 |
Resistant |
| ENSG00000239569.2 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044006768 |
Resistant |
| ENSG00000239653.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044115398 |
Resistant |
| ENSG00000243243.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02934958 |
Resistant |
| ENSG00000244945.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005147302 |
Resistant |
| ENSG00000245748.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020203558 |
Resistant |
| ENSG00000246898.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005831163 |
Resistant |
| ENSG00000249084.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031027842 |
Resistant |
| ENSG00000251022.2 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032827628 |
Resistant |
| ENSG00000251556.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043532857 |
Resistant |
| ENSG00000255571.2 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033926586 |
Resistant |
| ENSG00000255843.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026567545 |
Resistant |
| ENSG00000258136.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019108142 |
Resistant |
| ENSG00000258410.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040947982 |
Resistant |
| ENSG00000259206.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.0422165 |
Resistant |
| ENSG00000259310.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044187652 |
Resistant |
| ENSG00000259442.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046356059 |
Resistant |
| ENSG00000259668.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049636609 |
Resistant |
| ENSG00000260608.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036151831 |
Resistant |
| ENSG00000260905.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042456856 |
Resistant |
| ENSG00000260912.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035618656 |
Resistant |
| ENSG00000260973.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041326734 |
Resistant |
| ENSG00000261338.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038200817 |
Resistant |
| ENSG00000261670.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046691427 |
Resistant |
| ENSG00000262514.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015698618 |
Resistant |
| ENSG00000264635.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045800167 |
Resistant |
| ENSG00000265749.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00244236 |
Resistant |
| ENSG00000265800.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046482554 |
Resistant |
| ENSG00000266538.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012017945 |
Resistant |
| ENSG00000267244.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035674021 |
Resistant |
| ENSG00000268670.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026678462 |
Resistant |
| ENSG00000269535.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.010919181 |
Resistant |
| ENSG00000269961.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014266531 |
Resistant |
| ENSG00000270165.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039755854 |
Resistant |
| ENSG00000273032.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000265596 |
Resistant |
| ENSG00000166770.6 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.012645516 |
Resistant |
| ENSG00000223701.3 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.027710968 |
Resistant |
| ENSG00000229582.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.029607542 |
Resistant |
| ENSG00000230806.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.04916013 |
Resistant |
| ENSG00000237167.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.021916437 |
Resistant |
| ENSG00000254670.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.041027227 |
Resistant |
| ENSG00000257443.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.019813402 |
Resistant |
| ENSG00000259341.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.049248541 |
Resistant |
| ENSG00000270828.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.037465081 |
Resistant |
| ENSG00000272512.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.026225348 |
Resistant |
| ENSG00000273472.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.022677259 |
Resistant |
| ENSG00000181097.5 |
ABT-263 (navitoclax) |
Sarcoma |
0.045054588 |
Resistant |
| ENSG00000205041.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.031925704 |
Resistant |
| ENSG00000219665.4 |
ABT-263 (navitoclax) |
Sarcoma |
0.020668121 |
Resistant |
| ENSG00000220161.4 |
ABT-263 (navitoclax) |
Sarcoma |
0.000980722 |
Resistant |
| ENSG00000224621.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.004258739 |
Resistant |
| ENSG00000227959.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.022622127 |
Resistant |
| ENSG00000228798.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.040657292 |
Resistant |
| ENSG00000228939.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.02788497 |
Resistant |
| ENSG00000230266.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.03614123 |
Resistant |
| ENSG00000230534.2 |
ABT-263 (navitoclax) |
Sarcoma |
0.045445684 |
Resistant |
| ENSG00000231663.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.039395629 |
Resistant |
| ENSG00000232940.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.039516358 |
Resistant |
| ENSG00000234740.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.022022842 |
Resistant |
| ENSG00000234915.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.000962132 |
Resistant |
| ENSG00000235117.2 |
ABT-263 (navitoclax) |
Sarcoma |
0.045625654 |
Resistant |
| ENSG00000236256.5 |
ABT-263 (navitoclax) |
Sarcoma |
0.016451902 |
Resistant |
| ENSG00000250910.3 |
ABT-263 (navitoclax) |
Sarcoma |
0.011498036 |
Resistant |
| ENSG00000250988.3 |
ABT-263 (navitoclax) |
Sarcoma |
0.041520647 |
Resistant |
| ENSG00000253741.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.01244471 |
Resistant |
| ENSG00000254267.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.003605312 |
Resistant |
| ENSG00000254397.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.040068821 |
Resistant |
| ENSG00000254419.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.035321255 |
Resistant |
| ENSG00000255008.2 |
ABT-263 (navitoclax) |
Sarcoma |
0.044330399 |
Resistant |
| ENSG00000255557.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.034217349 |
Resistant |
| ENSG00000255857.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.028859916 |
Resistant |
| ENSG00000256546.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.018033496 |
Resistant |
| ENSG00000256742.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.007789118 |
Resistant |
| ENSG00000257410.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.013138436 |
Resistant |
| ENSG00000259083.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.042085487 |
Resistant |
| ENSG00000259933.2 |
ABT-263 (navitoclax) |
Sarcoma |
0.037659044 |
Resistant |
| ENSG00000260260.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.014974913 |
Resistant |
| ENSG00000260448.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.009726647 |
Resistant |
| ENSG00000260803.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.005110896 |
Resistant |
| ENSG00000261267.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.028124188 |
Resistant |
| ENSG00000262202.3 |
ABT-263 (navitoclax) |
Sarcoma |
0.022052865 |
Resistant |
| ENSG00000264940.2 |
ABT-263 (navitoclax) |
Sarcoma |
0.015581499 |
Resistant |
| ENSG00000266999.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.047515454 |
Resistant |
| ENSG00000268164.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.027040237 |
Resistant |
| ENSG00000272386.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.035051395 |
Resistant |
| ENSG00000272432.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.040472565 |
Resistant |
| ENSG00000272792.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.046253317 |
Resistant |
| ENSG00000175773.8 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.008963582 |
Resistant |
| ENSG00000196756.7 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.032064608 |
Resistant |
| ENSG00000214353.3 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.048036754 |
Resistant |
| ENSG00000223697.2 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.033033842 |
Resistant |
| ENSG00000223966.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.047483821 |
Resistant |
| ENSG00000225218.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.030647022 |
Resistant |
| ENSG00000225555.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.007282475 |
Resistant |
| ENSG00000226091.3 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.04852188 |
Resistant |
| ENSG00000226328.2 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.043474656 |
Resistant |
| ENSG00000226699.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.005166498 |
Resistant |
| ENSG00000227083.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.003695665 |
Resistant |
| ENSG00000227258.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.004716232 |
Resistant |
| ENSG00000228013.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.040412532 |
Resistant |
| ENSG00000228548.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.010020359 |
Resistant |
| ENSG00000228577.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.045139784 |
Resistant |
| ENSG00000229621.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.014811196 |
Resistant |
| ENSG00000229702.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.042803744 |
Resistant |
| ENSG00000229891.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.013877002 |
Resistant |
| ENSG00000230470.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.011608728 |
Resistant |
| ENSG00000231023.2 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.007248024 |
Resistant |
| ENSG00000231073.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.03788446 |
Resistant |
| ENSG00000231407.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.014731867 |
Resistant |
| ENSG00000231728.2 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.007820874 |
Resistant |
| ENSG00000232086.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.016701567 |
Resistant |
| ENSG00000232732.5 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.007628756 |
Resistant |
| ENSG00000232909.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.001725141 |
Resistant |
| ENSG00000233069.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.009795433 |
Resistant |
| ENSG00000233203.2 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.039806931 |
Resistant |
| ENSG00000233695.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.03994969 |
Resistant |
| ENSG00000233844.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.039786203 |
Resistant |
| ENSG00000234405.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.04614228 |
Resistant |
| ENSG00000234456.3 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.029064937 |
Resistant |
| ENSG00000234567.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.026287045 |
Resistant |
| ENSG00000234665.4 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.023603412 |
Resistant |
| ENSG00000234880.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.03695225 |
Resistant |
| ENSG00000234915.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.020487002 |
Resistant |
| ENSG00000235117.2 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.045654637 |
Resistant |
| ENSG00000235373.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.016376307 |
Resistant |
| ENSG00000236385.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.031984086 |
Resistant |
| ENSG00000236427.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.025739051 |
Resistant |
| ENSG00000236535.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.019729018 |
Resistant |
| ENSG00000236780.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.043607195 |
Resistant |
| ENSG00000236896.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.009354642 |
Resistant |
| ENSG00000237605.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.010901452 |
Resistant |
| ENSG00000238035.4 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.034344751 |
Resistant |
| ENSG00000238062.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.008080872 |
Resistant |
| ENSG00000240086.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.031356055 |
Resistant |
| ENSG00000241155.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.016604194 |
Resistant |
| ENSG00000241985.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.048375539 |
Resistant |
| ENSG00000242082.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.035715165 |
Resistant |
| ENSG00000244327.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.036733809 |
Resistant |
| ENSG00000244459.2 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.004224783 |
Resistant |
| ENSG00000245648.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.015492033 |
Resistant |
| ENSG00000246528.3 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.041110723 |
Resistant |
| ENSG00000247516.3 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.005357634 |
Resistant |
| ENSG00000248318.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.005725383 |
Resistant |
| ENSG00000248461.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.000238709 |
Resistant |
| ENSG00000248724.2 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.037755116 |
Resistant |
| ENSG00000249159.2 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.01275628 |
Resistant |
| ENSG00000249650.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.038437504 |
Resistant |
| ENSG00000249753.2 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.002600359 |
Resistant |
| ENSG00000249803.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.022881776 |
Resistant |
| ENSG00000249984.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.046243204 |
Resistant |
| ENSG00000250938.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.029615436 |
Resistant |
| ENSG00000251095.2 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.023519438 |
Resistant |
| ENSG00000251396.2 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.011153211 |
Resistant |
| ENSG00000253562.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.042289874 |
Resistant |
| ENSG00000253848.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.017567003 |
Resistant |
| ENSG00000254057.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.011678808 |
Resistant |
| ENSG00000254431.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.018925355 |
Resistant |
| ENSG00000254484.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.029910465 |
Resistant |
| ENSG00000254538.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.02559596 |
Resistant |
| ENSG00000254615.2 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.009034316 |
Resistant |
| ENSG00000255026.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.005299615 |
Resistant |
| ENSG00000255052.3 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.048058848 |
Resistant |
| ENSG00000255443.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.048363889 |
Resistant |
| ENSG00000255621.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.039873639 |
Resistant |
| ENSG00000255864.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.029660536 |
Resistant |
| ENSG00000256083.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.006141088 |
Resistant |
| ENSG00000256458.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.041350567 |
Resistant |
| ENSG00000256603.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.022811304 |
Resistant |
| ENSG00000258553.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.039720616 |
Resistant |
| ENSG00000259135.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.006558942 |
Resistant |
| ENSG00000259590.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.04922397 |
Resistant |
| ENSG00000260411.2 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.021048675 |
Resistant |
| ENSG00000260473.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.0140525 |
Resistant |
| ENSG00000260545.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.040536018 |
Resistant |
| ENSG00000260831.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.010991531 |
Resistant |
| ENSG00000261373.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.030816367 |
Resistant |
| ENSG00000261428.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.045582761 |
Resistant |
| ENSG00000261595.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.017989821 |
Resistant |
| ENSG00000261632.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.038348369 |
Resistant |
| ENSG00000262585.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.031086616 |
Resistant |
| ENSG00000262769.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.013352389 |
Resistant |
| ENSG00000263105.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.040857051 |
Resistant |
| ENSG00000264914.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.029422643 |
Resistant |
| ENSG00000265666.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.012904653 |
Resistant |
| ENSG00000266801.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.030702945 |
Resistant |
| ENSG00000266895.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.0091925 |
Resistant |
| ENSG00000267296.2 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.008604171 |
Resistant |
| ENSG00000267505.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.03353636 |
Resistant |
| ENSG00000267666.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.025818466 |
Resistant |
| ENSG00000267798.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.034050561 |
Resistant |
| ENSG00000268262.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.007543484 |
Resistant |
| ENSG00000269924.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.037504951 |
Resistant |
| ENSG00000270074.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.037609629 |
Resistant |
| ENSG00000271387.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.033788656 |
Resistant |
| ENSG00000271874.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.017099175 |
Resistant |
| ENSG00000272181.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.032514141 |
Resistant |
| ENSG00000272438.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.016440764 |
Resistant |
| ENSG00000272518.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.019934821 |
Resistant |
| ENSG00000272555.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.034352305 |
Resistant |
| ENSG00000272574.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.012688567 |
Resistant |
| ENSG00000272945.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.010244104 |
Resistant |
| ENSG00000273027.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.008103223 |
Resistant |
| ENSG00000273097.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.041862045 |
Resistant |
| ENSG00000273309.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.041040382 |
Resistant |
| ENSG00000175967.3 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.00207901 |
Sensitive |
| ENSG00000214407.3 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.047206251 |
Sensitive |
| ENSG00000219665.4 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.021835994 |
Sensitive |
| ENSG00000224885.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.049243315 |
Sensitive |
| ENSG00000225163.3 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.042171265 |
Sensitive |
| ENSG00000227071.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.030087202 |
Sensitive |
| ENSG00000227945.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.042858097 |
Sensitive |
| ENSG00000229867.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.016361297 |
Sensitive |
| ENSG00000231201.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.032488265 |
Sensitive |
| ENSG00000231760.2 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.037923626 |
Sensitive |
| ENSG00000232117.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.000984304 |
Sensitive |
| ENSG00000232593.2 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.03257925 |
Sensitive |
| ENSG00000232762.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.008630169 |
Sensitive |
| ENSG00000236869.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.005790773 |
Sensitive |
| ENSG00000237807.3 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.02306705 |
Sensitive |
| ENSG00000241479.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.016993213 |
Sensitive |
| ENSG00000242516.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.035362465 |
Sensitive |
| ENSG00000253893.2 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.031922057 |
Sensitive |
| ENSG00000254204.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.038792127 |
Sensitive |
| ENSG00000254409.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.016157249 |
Sensitive |
| ENSG00000254560.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.003719915 |
Sensitive |
| ENSG00000254606.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.013621349 |
Sensitive |
| ENSG00000254791.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.024765332 |
Sensitive |
| ENSG00000255322.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.011960248 |
Sensitive |
| ENSG00000256448.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.008662933 |
Sensitive |
| ENSG00000258620.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.021962609 |
Sensitive |
| ENSG00000258777.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.047765366 |
Sensitive |
| ENSG00000258825.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.001193575 |
Sensitive |
| ENSG00000259583.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.015535266 |
Sensitive |
| ENSG00000260366.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.04893495 |
Sensitive |
| ENSG00000260368.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.022486659 |
Sensitive |
| ENSG00000260635.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.038856881 |
Sensitive |
| ENSG00000261490.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.007564942 |
Sensitive |
| ENSG00000262147.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.032979617 |
Sensitive |
| ENSG00000262202.3 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.036866317 |
Sensitive |
| ENSG00000263069.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.044751623 |
Sensitive |
| ENSG00000263466.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.002747135 |
Sensitive |
| ENSG00000264812.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.044623914 |
Sensitive |
| ENSG00000267118.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.026071405 |
Sensitive |
| ENSG00000267263.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.047734495 |
Sensitive |
| ENSG00000267470.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.012749576 |
Sensitive |
| ENSG00000267934.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.04806893 |
Sensitive |
| ENSG00000268015.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.038540862 |
Sensitive |
| ENSG00000269102.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.029125637 |
Sensitive |
| ENSG00000269148.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.029575154 |
Sensitive |
| ENSG00000269487.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.019665231 |
Sensitive |
| ENSG00000269942.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.040615935 |
Sensitive |
| ENSG00000270062.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.038890381 |
Sensitive |
| ENSG00000271803.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.045054495 |
Sensitive |
| ENSG00000273133.1 |
ABT-263 (navitoclax) |
Bladder urothelial carcinoma |
0.009952836 |
Sensitive |
| ENSG00000170846.11 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.01015063 |
Sensitive |
| ENSG00000174365.15 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.01289988 |
Sensitive |
| ENSG00000179935.5 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.043017664 |
Sensitive |
| ENSG00000197308.4 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.047133635 |
Sensitive |
| ENSG00000205500.4 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.019597495 |
Sensitive |
| ENSG00000213742.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.002212403 |
Sensitive |
| ENSG00000215424.5 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.046970579 |
Sensitive |
| ENSG00000223891.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.044264589 |
Sensitive |
| ENSG00000224269.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.01647565 |
Sensitive |
| ENSG00000224276.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.011544287 |
Sensitive |
| ENSG00000224616.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.023829684 |
Sensitive |
| ENSG00000224805.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.042038516 |
Sensitive |
| ENSG00000225506.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.014868515 |
Sensitive |
| ENSG00000225555.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.011231608 |
Sensitive |
| ENSG00000225778.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.028456516 |
Sensitive |
| ENSG00000226310.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.013429961 |
Sensitive |
| ENSG00000226465.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.013797432 |
Sensitive |
| ENSG00000226696.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.03960529 |
Sensitive |
| ENSG00000226740.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.024065231 |
Sensitive |
| ENSG00000227155.3 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.020554647 |
Sensitive |
| ENSG00000227170.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.033489573 |
Sensitive |
| ENSG00000227374.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.044613029 |
Sensitive |
| ENSG00000228251.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.020592993 |
Sensitive |
| ENSG00000228265.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.002533386 |
Sensitive |
| ENSG00000228614.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.049540224 |
Sensitive |
| ENSG00000228705.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.048520995 |
Sensitive |
| ENSG00000230366.5 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.048582205 |
Sensitive |
| ENSG00000230648.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.036751419 |
Sensitive |
| ENSG00000231010.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.045077095 |
Sensitive |
| ENSG00000231149.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.044131442 |
Sensitive |
| ENSG00000231327.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.023455403 |
Sensitive |
| ENSG00000231512.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.02715695 |
Sensitive |
| ENSG00000231563.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.012227801 |
Sensitive |
| ENSG00000231646.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.021701509 |
Sensitive |
| ENSG00000231865.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.033707684 |
Sensitive |
| ENSG00000231944.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.044611548 |
Sensitive |
| ENSG00000232645.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.012636418 |
Sensitive |
| ENSG00000232656.3 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.026526221 |
Sensitive |
| ENSG00000232686.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.023986705 |
Sensitive |
| ENSG00000232876.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.043017302 |
Sensitive |
| ENSG00000232940.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.020202917 |
Sensitive |
| ENSG00000233017.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.01101132 |
Sensitive |
| ENSG00000233030.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.018899258 |
Sensitive |
| ENSG00000233757.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.006639494 |
Sensitive |
| ENSG00000233847.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.045889341 |
Sensitive |
| ENSG00000233862.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.048466901 |
Sensitive |
| ENSG00000234630.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.047345458 |
Sensitive |
| ENSG00000234694.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.046090316 |
Sensitive |
| ENSG00000234771.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.036953332 |
Sensitive |
| ENSG00000234772.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.044018291 |
Sensitive |
| ENSG00000234859.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.047051843 |
Sensitive |
| ENSG00000234997.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.00691902 |
Sensitive |
| ENSG00000235358.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.049091647 |
Sensitive |
| ENSG00000235806.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.035836497 |
Sensitive |
| ENSG00000235919.3 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.028004494 |
Sensitive |
| ENSG00000237476.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.047534202 |
Sensitive |
| ENSG00000237523.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.02732986 |
Sensitive |
| ENSG00000237594.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.025014643 |
Sensitive |
| ENSG00000238113.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.016982292 |
Sensitive |
| ENSG00000238197.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.039090805 |
Sensitive |
| ENSG00000240137.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.034953952 |
Sensitive |
| ENSG00000240211.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.000302301 |
Sensitive |
| ENSG00000240541.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.019382479 |
Sensitive |
| ENSG00000242686.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.038550649 |
Sensitive |
| ENSG00000242767.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.027822807 |
Sensitive |
| ENSG00000243350.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.028578043 |
Sensitive |
| ENSG00000243368.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.037264116 |
Sensitive |
| ENSG00000244733.4 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.041047522 |
Sensitive |
| ENSG00000244968.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.025280775 |
Sensitive |
| ENSG00000245768.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.026627589 |
Sensitive |
| ENSG00000246334.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.042007075 |
Sensitive |
| ENSG00000247137.4 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.027245987 |
Sensitive |
| ENSG00000247828.3 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.022943496 |
Sensitive |
| ENSG00000247877.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.021723964 |
Sensitive |
| ENSG00000249352.3 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.033996571 |
Sensitive |
| ENSG00000249859.3 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.012017284 |
Sensitive |
| ENSG00000250131.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.019573497 |
Sensitive |
| ENSG00000250362.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.035402833 |
Sensitive |
| ENSG00000250764.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.047160914 |
Sensitive |
| ENSG00000251141.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.048019728 |
Sensitive |
| ENSG00000251455.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.039439678 |
Sensitive |
| ENSG00000251666.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.010009011 |
Sensitive |
| ENSG00000253327.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.028331243 |
Sensitive |
| ENSG00000253712.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.005955901 |
Sensitive |
| ENSG00000253736.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.010102679 |
Sensitive |
| ENSG00000254165.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.041530743 |
Sensitive |
| ENSG00000254286.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.047509205 |
Sensitive |
| ENSG00000254363.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.026209028 |
Sensitive |
| ENSG00000255521.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.025543529 |
Sensitive |
| ENSG00000256603.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.01739103 |
Sensitive |
| ENSG00000256705.3 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.039695897 |
Sensitive |
| ENSG00000256982.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.01889237 |
Sensitive |
| ENSG00000257261.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.029709041 |
Sensitive |
| ENSG00000257337.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.026067959 |
Sensitive |
| ENSG00000258821.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.042424017 |
Sensitive |
| ENSG00000258926.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.028739537 |
Sensitive |
| ENSG00000259038.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.006864966 |
Sensitive |
| ENSG00000259274.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.034652196 |
Sensitive |
| ENSG00000259926.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.046331784 |
Sensitive |
| ENSG00000260156.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.038984932 |
Sensitive |
| ENSG00000260360.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.017386386 |
Sensitive |
| ENSG00000260509.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.043290921 |
Sensitive |
| ENSG00000260924.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.045784887 |
Sensitive |
| ENSG00000261135.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.02300553 |
Sensitive |
| ENSG00000261254.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.016862166 |
Sensitive |
| ENSG00000261431.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.022360711 |
Sensitive |
| ENSG00000261537.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.028245657 |
Sensitive |
| ENSG00000261971.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.018005327 |
Sensitive |
| ENSG00000262172.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.017985259 |
Sensitive |
| ENSG00000262202.3 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.04315844 |
Sensitive |
| ENSG00000262662.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.031071059 |
Sensitive |
| ENSG00000263400.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.037861287 |
Sensitive |
| ENSG00000265185.2 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.001816299 |
Sensitive |
| ENSG00000265282.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.029796937 |
Sensitive |
| ENSG00000265399.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.042329885 |
Sensitive |
| ENSG00000265912.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.020519635 |
Sensitive |
| ENSG00000266801.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.046211536 |
Sensitive |
| ENSG00000267432.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.038897719 |
Sensitive |
| ENSG00000267658.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.011442115 |
Sensitive |
| ENSG00000268605.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.02466311 |
Sensitive |
| ENSG00000269887.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.003420079 |
Sensitive |
| ENSG00000269894.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.027928566 |
Sensitive |
| ENSG00000269924.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.034295441 |
Sensitive |
| ENSG00000270019.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.049790613 |
Sensitive |
| ENSG00000270761.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.007510093 |
Sensitive |
| ENSG00000271151.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.038841915 |
Sensitive |
| ENSG00000271387.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.01138758 |
Sensitive |
| ENSG00000271888.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.048479342 |
Sensitive |
| ENSG00000272123.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.018149812 |
Sensitive |
| ENSG00000272183.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.0343408 |
Sensitive |
| ENSG00000272216.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.044882206 |
Sensitive |
| ENSG00000272265.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.006349157 |
Sensitive |
| ENSG00000272627.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.025650786 |
Sensitive |
| ENSG00000272688.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.037351268 |
Sensitive |
| ENSG00000272764.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.035274622 |
Sensitive |
| ENSG00000272769.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.013881481 |
Sensitive |
| ENSG00000272787.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.044155018 |
Sensitive |
| ENSG00000272829.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.009915435 |
Sensitive |
| ENSG00000272862.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.046646905 |
Sensitive |
| ENSG00000272954.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.038772976 |
Sensitive |
| ENSG00000273139.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.04657318 |
Sensitive |
| ENSG00000273148.1 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.035401694 |
Sensitive |
| ENSG00000175699.8 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.022599621 |
Sensitive |
| ENSG00000196756.7 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.02979346 |
Sensitive |
| ENSG00000223393.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.021805999 |
Sensitive |
| ENSG00000223935.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040975755 |
Sensitive |
| ENSG00000226007.2 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.043750419 |
Sensitive |
| ENSG00000227279.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031969445 |
Sensitive |
| ENSG00000227533.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045195249 |
Sensitive |
| ENSG00000230850.3 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017939159 |
Sensitive |
| ENSG00000231196.3 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.00317821 |
Sensitive |
| ENSG00000232907.3 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013695087 |
Sensitive |
| ENSG00000234232.2 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.024254996 |
Sensitive |
| ENSG00000234705.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032746014 |
Sensitive |
| ENSG00000234943.2 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046011669 |
Sensitive |
| ENSG00000236209.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023893609 |
Sensitive |
| ENSG00000240057.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013119875 |
Sensitive |
| ENSG00000242391.2 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.004877901 |
Sensitive |
| ENSG00000244198.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.01373903 |
Sensitive |
| ENSG00000244479.2 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027952102 |
Sensitive |
| ENSG00000251562.3 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.048178218 |
Sensitive |
| ENSG00000253112.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045941148 |
Sensitive |
| ENSG00000254484.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035681719 |
Sensitive |
| ENSG00000255045.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.01195741 |
Sensitive |
| ENSG00000257337.2 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039503665 |
Sensitive |
| ENSG00000260941.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03567633 |
Sensitive |
| ENSG00000261068.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035257987 |
Sensitive |
| ENSG00000261485.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026058834 |
Sensitive |
| ENSG00000261644.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03312838 |
Sensitive |
| ENSG00000262319.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.008490319 |
Sensitive |
| ENSG00000262979.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.016180142 |
Sensitive |
| ENSG00000263923.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038077176 |
Sensitive |
| ENSG00000265451.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.014090462 |
Sensitive |
| ENSG00000265479.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042520948 |
Sensitive |
| ENSG00000266965.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04016945 |
Sensitive |
| ENSG00000267481.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.007373039 |
Sensitive |
| ENSG00000269172.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.01410753 |
Sensitive |
| ENSG00000270761.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.009296932 |
Sensitive |
| ENSG00000271855.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.007654418 |
Sensitive |
| ENSG00000272457.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04875724 |
Sensitive |
| ENSG00000272791.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032019638 |
Sensitive |
| ENSG00000272796.1 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015029009 |
Sensitive |
| ENSG00000157306.10 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.021750991 |
Sensitive |
| ENSG00000205500.4 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.048424432 |
Sensitive |
| ENSG00000224222.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.025660602 |
Sensitive |
| ENSG00000227256.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.015610097 |
Sensitive |
| ENSG00000227637.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.021367704 |
Sensitive |
| ENSG00000229311.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.033472262 |
Sensitive |
| ENSG00000229512.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.017434202 |
Sensitive |
| ENSG00000229832.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.010763086 |
Sensitive |
| ENSG00000230155.2 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.045443573 |
Sensitive |
| ENSG00000230587.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.040938666 |
Sensitive |
| ENSG00000231294.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.023919264 |
Sensitive |
| ENSG00000232274.2 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.017236237 |
Sensitive |
| ENSG00000232336.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.032148541 |
Sensitive |
| ENSG00000233056.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.036622181 |
Sensitive |
| ENSG00000236772.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.048329556 |
Sensitive |
| ENSG00000237453.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.004033658 |
Sensitive |
| ENSG00000246090.2 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.011949574 |
Sensitive |
| ENSG00000248844.2 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.032219112 |
Sensitive |
| ENSG00000254485.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.020757371 |
Sensitive |
| ENSG00000255325.2 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.037622214 |
Sensitive |
| ENSG00000257086.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.016293084 |
Sensitive |
| ENSG00000257337.2 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.031817647 |
Sensitive |
| ENSG00000258413.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.006286281 |
Sensitive |
| ENSG00000258450.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.041676934 |
Sensitive |
| ENSG00000259398.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.022959059 |
Sensitive |
| ENSG00000263393.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.015250516 |
Sensitive |
| ENSG00000265787.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.000851779 |
Sensitive |
| ENSG00000267016.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.020475102 |
Sensitive |
| ENSG00000267263.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.008636593 |
Sensitive |
| ENSG00000267530.2 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.049241055 |
Sensitive |
| ENSG00000268812.2 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.027070613 |
Sensitive |
| ENSG00000269889.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.026949028 |
Sensitive |
| ENSG00000269973.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.046702572 |
Sensitive |
| ENSG00000270157.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.011100955 |
Sensitive |
| ENSG00000270949.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.044310146 |
Sensitive |
| ENSG00000272950.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.028904535 |
Sensitive |
| ENSG00000273183.1 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.035212521 |
Sensitive |
| ENSG00000224029.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003694415 |
Sensitive |
| ENSG00000225914.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046290795 |
Sensitive |
| ENSG00000226533.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049065479 |
Sensitive |
| ENSG00000234915.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041249774 |
Sensitive |
| ENSG00000240476.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034317847 |
Sensitive |
| ENSG00000254495.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028024593 |
Sensitive |
| ENSG00000259805.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049440592 |
Sensitive |
| ENSG00000260017.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026597093 |
Sensitive |
| ENSG00000265992.1 |
ABT-263 (navitoclax) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022943415 |
Sensitive |
| ENSG00000206573.4 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.036614133 |
Sensitive |
| ENSG00000224251.2 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.039920428 |
Sensitive |
| ENSG00000225527.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.014773945 |
Sensitive |
| ENSG00000226950.2 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.018898148 |
Sensitive |
| ENSG00000230424.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.001234529 |
Sensitive |
| ENSG00000231481.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.031969128 |
Sensitive |
| ENSG00000231663.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.014468904 |
Sensitive |
| ENSG00000232600.2 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.0043779 |
Sensitive |
| ENSG00000233775.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.010672098 |
Sensitive |
| ENSG00000236833.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.033247689 |
Sensitive |
| ENSG00000237126.4 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.003861613 |
Sensitive |
| ENSG00000238043.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.011899274 |
Sensitive |
| ENSG00000242086.4 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.044769637 |
Sensitive |
| ENSG00000246790.2 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.021333111 |
Sensitive |
| ENSG00000249637.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.027012239 |
Sensitive |
| ENSG00000253695.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.004999314 |
Sensitive |
| ENSG00000254433.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.046608566 |
Sensitive |
| ENSG00000254560.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.025045285 |
Sensitive |
| ENSG00000254662.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.011133302 |
Sensitive |
| ENSG00000254973.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.018039973 |
Sensitive |
| ENSG00000255182.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.044788714 |
Sensitive |
| ENSG00000255651.2 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.03527091 |
Sensitive |
| ENSG00000255857.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.022369586 |
Sensitive |
| ENSG00000258725.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.027738589 |
Sensitive |
| ENSG00000258982.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.033402837 |
Sensitive |
| ENSG00000259514.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.04396966 |
Sensitive |
| ENSG00000259758.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.013522379 |
Sensitive |
| ENSG00000259943.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.033671434 |
Sensitive |
| ENSG00000260917.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.037862666 |
Sensitive |
| ENSG00000261268.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.00728582 |
Sensitive |
| ENSG00000261338.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.007808509 |
Sensitive |
| ENSG00000261428.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.02700192 |
Sensitive |
| ENSG00000261512.2 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.046491244 |
Sensitive |
| ENSG00000261526.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.022609638 |
Sensitive |
| ENSG00000262412.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.019998254 |
Sensitive |
| ENSG00000265778.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.013860387 |
Sensitive |
| ENSG00000267118.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.045835558 |
Sensitive |
| ENSG00000267232.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.020942756 |
Sensitive |
| ENSG00000268564.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.025091793 |
Sensitive |
| ENSG00000269400.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.042747764 |
Sensitive |
| ENSG00000270052.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.041307475 |
Sensitive |
| ENSG00000270964.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.035731769 |
Sensitive |
| ENSG00000271751.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.000206071 |
Sensitive |
| ENSG00000271803.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.034835415 |
Sensitive |
| ENSG00000271975.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.016732333 |
Sensitive |
| ENSG00000272030.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.046686617 |
Sensitive |
| ENSG00000273428.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.049447276 |
Sensitive |
| ENSG00000214773.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.013443864 |
Sensitive |
| ENSG00000226920.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.009187164 |
Sensitive |
| ENSG00000227045.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.02758782 |
Sensitive |
| ENSG00000254495.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.046323883 |
Sensitive |
| ENSG00000269924.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.047056952 |
Sensitive |
| ENSG00000273096.1 |
ABT-263 (navitoclax) |
Chronic Lymphocytic Leukemia |
0.033599092 |
Sensitive |
| ENSG00000170846.11 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.029557178 |
Sensitive |
| ENSG00000179818.9 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.035218815 |
Sensitive |
| ENSG00000185203.7 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.024007559 |
Sensitive |
| ENSG00000197332.7 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.031252775 |
Sensitive |
| ENSG00000203362.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.014700982 |
Sensitive |
| ENSG00000203441.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.031257726 |
Sensitive |
| ENSG00000203739.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.030978488 |
Sensitive |
| ENSG00000203809.5 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.031904739 |
Sensitive |
| ENSG00000213971.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.04805791 |
Sensitive |
| ENSG00000215866.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.038301141 |
Sensitive |
| ENSG00000223571.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.007604823 |
Sensitive |
| ENSG00000224032.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.032875921 |
Sensitive |
| ENSG00000224043.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.026520833 |
Sensitive |
| ENSG00000224078.8 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.003059861 |
Sensitive |
| ENSG00000224276.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.020125386 |
Sensitive |
| ENSG00000224429.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.026170242 |
Sensitive |
| ENSG00000224713.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.041615606 |
Sensitive |
| ENSG00000225096.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.019148718 |
Sensitive |
| ENSG00000225439.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.032667654 |
Sensitive |
| ENSG00000225930.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.044759042 |
Sensitive |
| ENSG00000225975.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.049463086 |
Sensitive |
| ENSG00000226581.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.027979333 |
Sensitive |
| ENSG00000226904.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.044733758 |
Sensitive |
| ENSG00000226920.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.006190182 |
Sensitive |
| ENSG00000227248.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.040612243 |
Sensitive |
| ENSG00000227285.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.004874681 |
Sensitive |
| ENSG00000227354.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.005697278 |
Sensitive |
| ENSG00000227372.6 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.02247362 |
Sensitive |
| ENSG00000227487.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.04331956 |
Sensitive |
| ENSG00000227704.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.045990734 |
Sensitive |
| ENSG00000228614.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.040967261 |
Sensitive |
| ENSG00000228629.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.048064509 |
Sensitive |
| ENSG00000228723.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.029172044 |
Sensitive |
| ENSG00000228906.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.007753517 |
Sensitive |
| ENSG00000228939.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.030742291 |
Sensitive |
| ENSG00000229587.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.027476045 |
Sensitive |
| ENSG00000229980.4 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.025239029 |
Sensitive |
| ENSG00000230530.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.030003067 |
Sensitive |
| ENSG00000230736.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.008530335 |
Sensitive |
| ENSG00000231439.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.041745498 |
Sensitive |
| ENSG00000231840.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.046890149 |
Sensitive |
| ENSG00000231992.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.044937461 |
Sensitive |
| ENSG00000231993.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.031281022 |
Sensitive |
| ENSG00000232640.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.047718764 |
Sensitive |
| ENSG00000232677.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.032447186 |
Sensitive |
| ENSG00000232828.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.013155918 |
Sensitive |
| ENSG00000233033.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.032185818 |
Sensitive |
| ENSG00000233757.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.029211631 |
Sensitive |
| ENSG00000234160.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.024727719 |
Sensitive |
| ENSG00000234233.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.023186163 |
Sensitive |
| ENSG00000234286.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.046554476 |
Sensitive |
| ENSG00000234689.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.047325294 |
Sensitive |
| ENSG00000234771.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.045705829 |
Sensitive |
| ENSG00000234848.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.027486016 |
Sensitive |
| ENSG00000234996.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.040630345 |
Sensitive |
| ENSG00000235381.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.029320498 |
Sensitive |
| ENSG00000235499.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.048867715 |
Sensitive |
| ENSG00000235760.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.029859973 |
Sensitive |
| ENSG00000235852.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.018364733 |
Sensitive |
| ENSG00000235954.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.043281076 |
Sensitive |
| ENSG00000236711.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.038371442 |
Sensitive |
| ENSG00000236901.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.022437729 |
Sensitive |
| ENSG00000237248.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.041845395 |
Sensitive |
| ENSG00000237291.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.036253983 |
Sensitive |
| ENSG00000237594.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.024251002 |
Sensitive |
| ENSG00000237976.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.042886064 |
Sensitive |
| ENSG00000238186.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.042638686 |
Sensitive |
| ENSG00000238287.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.034839581 |
Sensitive |
| ENSG00000241954.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.016364721 |
Sensitive |
| ENSG00000242553.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.037337097 |
Sensitive |
| ENSG00000245498.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.010477365 |
Sensitive |
| ENSG00000245904.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.021364573 |
Sensitive |
| ENSG00000245910.4 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.039865228 |
Sensitive |
| ENSG00000245928.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.043010103 |
Sensitive |
| ENSG00000245975.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.02205002 |
Sensitive |
| ENSG00000246465.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.025952311 |
Sensitive |
| ENSG00000246792.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.021592365 |
Sensitive |
| ENSG00000247373.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.036860806 |
Sensitive |
| ENSG00000247516.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.034349982 |
Sensitive |
| ENSG00000247556.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.000241808 |
Sensitive |
| ENSG00000247708.3 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.024530369 |
Sensitive |
| ENSG00000248774.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.039270801 |
Sensitive |
| ENSG00000249494.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.010934222 |
Sensitive |
| ENSG00000249602.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.028389245 |
Sensitive |
| ENSG00000250802.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.029924561 |
Sensitive |
| ENSG00000250820.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.001412644 |
Sensitive |
| ENSG00000251298.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.044418697 |
Sensitive |
| ENSG00000253576.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.028764416 |
Sensitive |
| ENSG00000253978.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.046088387 |
Sensitive |
| ENSG00000254459.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.034985126 |
Sensitive |
| ENSG00000254489.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.00130448 |
Sensitive |
| ENSG00000254691.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.013556921 |
Sensitive |
| ENSG00000255027.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.034324486 |
Sensitive |
| ENSG00000255571.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.038781549 |
Sensitive |
| ENSG00000256712.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.018842751 |
Sensitive |
| ENSG00000257151.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.02925412 |
Sensitive |
| ENSG00000257272.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.044792892 |
Sensitive |
| ENSG00000257647.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.023935151 |
Sensitive |
| ENSG00000257660.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.022838759 |
Sensitive |
| ENSG00000258260.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.04127731 |
Sensitive |
| ENSG00000258556.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.010248517 |
Sensitive |
| ENSG00000258789.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.027700909 |
Sensitive |
| ENSG00000258920.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.006323476 |
Sensitive |
| ENSG00000259540.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.033069692 |
Sensitive |
| ENSG00000259548.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.033490735 |
Sensitive |
| ENSG00000259623.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.018642987 |
Sensitive |
| ENSG00000259959.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.027759014 |
Sensitive |
| ENSG00000260248.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.020172211 |
Sensitive |
| ENSG00000260293.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.023274377 |
Sensitive |
| ENSG00000260306.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.043372326 |
Sensitive |
| ENSG00000260361.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.049461913 |
Sensitive |
| ENSG00000260388.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.003968106 |
Sensitive |
| ENSG00000260400.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.037225728 |
Sensitive |
| ENSG00000260614.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.049001809 |
Sensitive |
| ENSG00000260743.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.037005743 |
Sensitive |
| ENSG00000260871.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.003131072 |
Sensitive |
| ENSG00000260874.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.040519104 |
Sensitive |
| ENSG00000260973.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.029308115 |
Sensitive |
| ENSG00000261069.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.027067155 |
Sensitive |
| ENSG00000261167.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.015401184 |
Sensitive |
| ENSG00000261288.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.04959309 |
Sensitive |
| ENSG00000261533.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.039269127 |
Sensitive |
| ENSG00000261775.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.035168706 |
Sensitive |
| ENSG00000261799.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.018352444 |
Sensitive |
| ENSG00000262222.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.036666975 |
Sensitive |
| ENSG00000263603.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.043377453 |
Sensitive |
| ENSG00000263906.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.044508819 |
Sensitive |
| ENSG00000264647.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.037641126 |
Sensitive |
| ENSG00000264860.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.038670391 |
Sensitive |
| ENSG00000264885.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.04848109 |
Sensitive |
| ENSG00000265242.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.010451395 |
Sensitive |
| ENSG00000265443.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.020055954 |
Sensitive |
| ENSG00000266935.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.045136932 |
Sensitive |
| ENSG00000267002.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.039702964 |
Sensitive |
| ENSG00000267128.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.028251003 |
Sensitive |
| ENSG00000267152.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.007638525 |
Sensitive |
| ENSG00000267249.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.033930529 |
Sensitive |
| ENSG00000267254.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.013806153 |
Sensitive |
| ENSG00000267381.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.016976684 |
Sensitive |
| ENSG00000267481.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.034862451 |
Sensitive |
| ENSG00000267581.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.007601637 |
Sensitive |
| ENSG00000267886.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.043553932 |
Sensitive |
| ENSG00000269107.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.032829466 |
Sensitive |
| ENSG00000269425.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.048274462 |
Sensitive |
| ENSG00000269814.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.034179284 |
Sensitive |
| ENSG00000269983.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.017303294 |
Sensitive |
| ENSG00000270018.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.027137908 |
Sensitive |
| ENSG00000270068.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.021762648 |
Sensitive |
| ENSG00000270081.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.029354781 |
Sensitive |
| ENSG00000270084.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.036774392 |
Sensitive |
| ENSG00000270127.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.038113456 |
Sensitive |
| ENSG00000270173.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.048205376 |
Sensitive |
| ENSG00000270189.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.04949394 |
Sensitive |
| ENSG00000270246.2 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.001667792 |
Sensitive |
| ENSG00000271347.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.01799398 |
Sensitive |
| ENSG00000272216.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.043792724 |
Sensitive |
| ENSG00000272308.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.042726784 |
Sensitive |
| ENSG00000272335.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.030811066 |
Sensitive |
| ENSG00000272373.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.03046875 |
Sensitive |
| ENSG00000272375.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.016895429 |
Sensitive |
| ENSG00000272440.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.019830576 |
Sensitive |
| ENSG00000272452.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.04498701 |
Sensitive |
| ENSG00000272798.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.020680512 |
Sensitive |
| ENSG00000272846.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.004887923 |
Sensitive |
| ENSG00000272855.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.017695725 |
Sensitive |
| ENSG00000272888.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.007364765 |
Sensitive |
| ENSG00000272912.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.024082396 |
Sensitive |
| ENSG00000272942.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.037883444 |
Sensitive |
| ENSG00000272954.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.048445678 |
Sensitive |
| ENSG00000272977.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.047180394 |
Sensitive |
| ENSG00000272989.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.008076106 |
Sensitive |
| ENSG00000273247.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.024275748 |
Sensitive |
| ENSG00000273308.1 |
ABT-263 (navitoclax) |
Brain lower grade glioma |
0.043428681 |
Sensitive |
| ENSG00000157306.10 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.039214715 |
Sensitive |
| ENSG00000203650.3 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.040345744 |
Sensitive |
| ENSG00000223461.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.001667024 |
Sensitive |
| ENSG00000224251.2 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.012531257 |
Sensitive |
| ENSG00000224460.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.021099381 |
Sensitive |
| ENSG00000224939.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.024803365 |
Sensitive |
| ENSG00000225218.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.032820943 |
Sensitive |
| ENSG00000225572.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.038948529 |
Sensitive |
| ENSG00000228412.2 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.028416814 |
Sensitive |
| ENSG00000228506.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.019016735 |
Sensitive |
| ENSG00000229589.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.034879043 |
Sensitive |
| ENSG00000230806.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.019502549 |
Sensitive |
| ENSG00000231028.4 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.031440161 |
Sensitive |
| ENSG00000231154.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.049799512 |
Sensitive |
| ENSG00000231346.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.00179298 |
Sensitive |
| ENSG00000232224.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.006227888 |
Sensitive |
| ENSG00000232732.5 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.018442638 |
Sensitive |
| ENSG00000234567.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.009955022 |
Sensitive |
| ENSG00000235426.2 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.024794468 |
Sensitive |
| ENSG00000240288.3 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.020974971 |
Sensitive |
| ENSG00000241770.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.04349503 |
Sensitive |
| ENSG00000242569.3 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.046974336 |
Sensitive |
| ENSG00000245748.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.026209648 |
Sensitive |
| ENSG00000246250.2 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.033158091 |
Sensitive |
| ENSG00000247400.3 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.027351082 |
Sensitive |
| ENSG00000251615.3 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.000874684 |
Sensitive |
| ENSG00000257443.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.036715133 |
Sensitive |
| ENSG00000257894.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.031926162 |
Sensitive |
| ENSG00000258334.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.022734523 |
Sensitive |
| ENSG00000259294.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.018126999 |
Sensitive |
| ENSG00000259408.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.028848277 |
Sensitive |
| ENSG00000259416.2 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.002399124 |
Sensitive |
| ENSG00000260034.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.040971123 |
Sensitive |
| ENSG00000260101.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.013127854 |
Sensitive |
| ENSG00000260751.2 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.010103997 |
Sensitive |
| ENSG00000260896.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.033246088 |
Sensitive |
| ENSG00000261008.2 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.015829108 |
Sensitive |
| ENSG00000261051.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.038409023 |
Sensitive |
| ENSG00000261118.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.016941701 |
Sensitive |
| ENSG00000262703.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.028743681 |
Sensitive |
| ENSG00000266936.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.04562882 |
Sensitive |
| ENSG00000266993.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.047372817 |
Sensitive |
| ENSG00000267244.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.026033026 |
Sensitive |
| ENSG00000267274.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.028337673 |
Sensitive |
| ENSG00000267481.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.032575577 |
Sensitive |
| ENSG00000267934.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.008649278 |
Sensitive |
| ENSG00000268564.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.022623413 |
Sensitive |
| ENSG00000269489.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.035061097 |
Sensitive |
| ENSG00000269560.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.044330215 |
Sensitive |
| ENSG00000271789.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.041342327 |
Sensitive |
| ENSG00000271997.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.027349912 |
Sensitive |
| ENSG00000273004.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.014697331 |
Sensitive |
| ENSG00000273342.1 |
ABT-263 (navitoclax) |
Liver hepatocellular carcinoma |
0.01249967 |
Sensitive |
| ENSG00000196421.3 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.045540255 |
Sensitive |
| ENSG00000196972.6 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.046427572 |
Sensitive |
| ENSG00000197291.4 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.016911002 |
Sensitive |
| ENSG00000205837.3 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.029582927 |
Sensitive |
| ENSG00000223561.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.036933962 |
Sensitive |
| ENSG00000223812.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.040904047 |
Sensitive |
| ENSG00000224713.3 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.037250766 |
Sensitive |
| ENSG00000226207.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.041204753 |
Sensitive |
| ENSG00000226390.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.048216257 |
Sensitive |
| ENSG00000227188.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.001706497 |
Sensitive |
| ENSG00000227285.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.034367175 |
Sensitive |
| ENSG00000227487.3 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.014562629 |
Sensitive |
| ENSG00000228151.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.020125633 |
Sensitive |
| ENSG00000229325.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.016725108 |
Sensitive |
| ENSG00000229891.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.048986573 |
Sensitive |
| ENSG00000230107.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.043420717 |
Sensitive |
| ENSG00000230910.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.03690429 |
Sensitive |
| ENSG00000232377.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.038986789 |
Sensitive |
| ENSG00000233293.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.032343996 |
Sensitive |
| ENSG00000233906.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.029190915 |
Sensitive |
| ENSG00000234394.4 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.012405876 |
Sensitive |
| ENSG00000234535.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.027803751 |
Sensitive |
| ENSG00000235872.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.010888043 |
Sensitive |
| ENSG00000236262.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.038282288 |
Sensitive |
| ENSG00000237152.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.049802971 |
Sensitive |
| ENSG00000237159.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.011566 |
Sensitive |
| ENSG00000237512.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.039433288 |
Sensitive |
| ENSG00000240907.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.041805025 |
Sensitive |
| ENSG00000241054.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.030527373 |
Sensitive |
| ENSG00000244302.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.014907409 |
Sensitive |
| ENSG00000244332.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.0366347 |
Sensitive |
| ENSG00000245067.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.047577316 |
Sensitive |
| ENSG00000246528.3 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.039381679 |
Sensitive |
| ENSG00000246627.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.038458728 |
Sensitive |
| ENSG00000246859.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.032925143 |
Sensitive |
| ENSG00000247416.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.047542789 |
Sensitive |
| ENSG00000248774.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.008279496 |
Sensitive |
| ENSG00000249307.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.046395485 |
Sensitive |
| ENSG00000249430.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.040484554 |
Sensitive |
| ENSG00000249487.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.049781734 |
Sensitive |
| ENSG00000250366.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.018813722 |
Sensitive |
| ENSG00000250699.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.043661041 |
Sensitive |
| ENSG00000251216.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.038744016 |
Sensitive |
| ENSG00000251309.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.01592565 |
Sensitive |
| ENSG00000253187.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.049800752 |
Sensitive |
| ENSG00000253477.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.012519469 |
Sensitive |
| ENSG00000253535.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.02312705 |
Sensitive |
| ENSG00000253618.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.007131047 |
Sensitive |
| ENSG00000253978.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.016794662 |
Sensitive |
| ENSG00000254314.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.045447477 |
Sensitive |
| ENSG00000254510.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.049393763 |
Sensitive |
| ENSG00000254664.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.035725615 |
Sensitive |
| ENSG00000254687.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.039885713 |
Sensitive |
| ENSG00000255020.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.037259138 |
Sensitive |
| ENSG00000255027.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.038097605 |
Sensitive |
| ENSG00000255474.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.034546075 |
Sensitive |
| ENSG00000255571.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.048807601 |
Sensitive |
| ENSG00000256321.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.049629368 |
Sensitive |
| ENSG00000256596.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.015150148 |
Sensitive |
| ENSG00000257272.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.048843832 |
Sensitive |
| ENSG00000257467.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.03109112 |
Sensitive |
| ENSG00000258520.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.038256174 |
Sensitive |
| ENSG00000258825.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.023498144 |
Sensitive |
| ENSG00000258998.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.019509488 |
Sensitive |
| ENSG00000259073.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.032748102 |
Sensitive |
| ENSG00000259126.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.047855816 |
Sensitive |
| ENSG00000259219.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.023539787 |
Sensitive |
| ENSG00000259241.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.017436282 |
Sensitive |
| ENSG00000259296.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.041152559 |
Sensitive |
| ENSG00000259462.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.010820784 |
Sensitive |
| ENSG00000259606.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.015476766 |
Sensitive |
| ENSG00000259650.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.036750842 |
Sensitive |
| ENSG00000259792.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.015543055 |
Sensitive |
| ENSG00000259834.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.043870468 |
Sensitive |
| ENSG00000259886.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.037014238 |
Sensitive |
| ENSG00000260306.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.033295515 |
Sensitive |
| ENSG00000260400.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.047819366 |
Sensitive |
| ENSG00000260411.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.039163288 |
Sensitive |
| ENSG00000260447.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.038602662 |
Sensitive |
| ENSG00000260469.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.034114347 |
Sensitive |
| ENSG00000260583.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.039588315 |
Sensitive |
| ENSG00000260614.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.020469369 |
Sensitive |
| ENSG00000260661.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.020674508 |
Sensitive |
| ENSG00000260905.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.042139145 |
Sensitive |
| ENSG00000260931.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.04140221 |
Sensitive |
| ENSG00000261634.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.046224587 |
Sensitive |
| ENSG00000261978.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.039050581 |
Sensitive |
| ENSG00000262951.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.011406242 |
Sensitive |
| ENSG00000263120.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.036373626 |
Sensitive |
| ENSG00000263938.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.021225742 |
Sensitive |
| ENSG00000265222.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.029281142 |
Sensitive |
| ENSG00000266930.2 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.026133553 |
Sensitive |
| ENSG00000266999.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.025379561 |
Sensitive |
| ENSG00000267414.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.045411042 |
Sensitive |
| ENSG00000267563.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.017305442 |
Sensitive |
| ENSG00000267583.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.003184482 |
Sensitive |
| ENSG00000267651.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.024363934 |
Sensitive |
| ENSG00000267940.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.01906759 |
Sensitive |
| ENSG00000268601.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.005354648 |
Sensitive |
| ENSG00000269694.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.035690538 |
Sensitive |
| ENSG00000269736.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.025492036 |
Sensitive |
| ENSG00000269752.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.044909596 |
Sensitive |
| ENSG00000269792.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.042269247 |
Sensitive |
| ENSG00000270062.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.011223332 |
Sensitive |
| ENSG00000270173.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.044611604 |
Sensitive |
| ENSG00000270750.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.049139426 |
Sensitive |
| ENSG00000270988.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.029252649 |
Sensitive |
| ENSG00000271738.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.001552884 |
Sensitive |
| ENSG00000271803.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.028240557 |
Sensitive |
| ENSG00000271830.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.010717113 |
Sensitive |
| ENSG00000271948.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.040223589 |
Sensitive |
| ENSG00000272079.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.042123908 |
Sensitive |
| ENSG00000272167.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.048651143 |
Sensitive |
| ENSG00000272343.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.023498513 |
Sensitive |
| ENSG00000272416.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.005112666 |
Sensitive |
| ENSG00000272828.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.019145144 |
Sensitive |
| ENSG00000272859.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.011005795 |
Sensitive |
| ENSG00000272989.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.045870942 |
Sensitive |
| ENSG00000273081.1 |
ABT-263 (navitoclax) |
Lung squamous cell carcinoma |
0.046783794 |
Sensitive |
| ENSG00000226007.2 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014713559 |
Sensitive |
| ENSG00000228661.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037457532 |
Sensitive |
| ENSG00000231327.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038927222 |
Sensitive |
| ENSG00000232194.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034111894 |
Sensitive |
| ENSG00000232412.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041390681 |
Sensitive |
| ENSG00000242516.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000533051 |
Sensitive |
| ENSG00000248810.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024310517 |
Sensitive |
| ENSG00000257252.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032964122 |
Sensitive |
| ENSG00000257449.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046999351 |
Sensitive |
| ENSG00000259974.2 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045781043 |
Sensitive |
| ENSG00000262468.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029871608 |
Sensitive |
| ENSG00000267637.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008982072 |
Sensitive |
| ENSG00000271147.3 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035372353 |
Sensitive |
| ENSG00000273265.1 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03126039 |
Sensitive |
| ENSG00000005206.12 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.010641457 |
Sensitive |
| ENSG00000088970.11 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.045445388 |
Sensitive |
| ENSG00000177853.10 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.010668259 |
Sensitive |
| ENSG00000203709.5 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.018530738 |
Sensitive |
| ENSG00000205500.4 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.007718629 |
Sensitive |
| ENSG00000215190.4 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.048746226 |
Sensitive |
| ENSG00000223522.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.045217027 |
Sensitive |
| ENSG00000223669.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.04662288 |
Sensitive |
| ENSG00000223695.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.028944469 |
Sensitive |
| ENSG00000223768.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.027246661 |
Sensitive |
| ENSG00000224093.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.027529239 |
Sensitive |
| ENSG00000224490.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.009049591 |
Sensitive |
| ENSG00000224635.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.047138379 |
Sensitive |
| ENSG00000224855.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.042653599 |
Sensitive |
| ENSG00000224888.3 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.048751664 |
Sensitive |
| ENSG00000225032.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.022175217 |
Sensitive |
| ENSG00000225234.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.014897629 |
Sensitive |
| ENSG00000225778.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.026632786 |
Sensitive |
| ENSG00000226287.3 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.044205791 |
Sensitive |
| ENSG00000226312.3 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.022915562 |
Sensitive |
| ENSG00000226824.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.030609736 |
Sensitive |
| ENSG00000227006.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.044359949 |
Sensitive |
| ENSG00000227543.3 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.025296004 |
Sensitive |
| ENSG00000227598.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.028677482 |
Sensitive |
| ENSG00000228079.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.020710151 |
Sensitive |
| ENSG00000228140.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.017658074 |
Sensitive |
| ENSG00000228274.3 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.028337033 |
Sensitive |
| ENSG00000228302.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.040015075 |
Sensitive |
| ENSG00000228686.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.024901692 |
Sensitive |
| ENSG00000228817.3 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.025269176 |
Sensitive |
| ENSG00000228839.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.010357451 |
Sensitive |
| ENSG00000230082.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.045338353 |
Sensitive |
| ENSG00000230105.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.040337095 |
Sensitive |
| ENSG00000230730.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.029564353 |
Sensitive |
| ENSG00000230732.3 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.017863765 |
Sensitive |
| ENSG00000230753.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.034020301 |
Sensitive |
| ENSG00000230912.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.039927993 |
Sensitive |
| ENSG00000231081.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.010705332 |
Sensitive |
| ENSG00000231201.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.006001992 |
Sensitive |
| ENSG00000231611.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.028004987 |
Sensitive |
| ENSG00000231691.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.00752847 |
Sensitive |
| ENSG00000231920.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.001157251 |
Sensitive |
| ENSG00000231993.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.035037537 |
Sensitive |
| ENSG00000232034.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.02980552 |
Sensitive |
| ENSG00000232600.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.032167419 |
Sensitive |
| ENSG00000232931.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.046964961 |
Sensitive |
| ENSG00000232940.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.034708431 |
Sensitive |
| ENSG00000233360.4 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.031352743 |
Sensitive |
| ENSG00000233847.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.005321648 |
Sensitive |
| ENSG00000234006.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.045909236 |
Sensitive |
| ENSG00000234155.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.033058287 |
Sensitive |
| ENSG00000234478.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.022226335 |
Sensitive |
| ENSG00000234902.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.027339932 |
Sensitive |
| ENSG00000235245.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.023807711 |
Sensitive |
| ENSG00000235269.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.005175891 |
Sensitive |
| ENSG00000235381.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.023540638 |
Sensitive |
| ENSG00000235408.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.02031856 |
Sensitive |
| ENSG00000235760.3 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.007407644 |
Sensitive |
| ENSG00000235772.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.008060662 |
Sensitive |
| ENSG00000235837.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.04605113 |
Sensitive |
| ENSG00000235908.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.015863847 |
Sensitive |
| ENSG00000236337.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.044464968 |
Sensitive |
| ENSG00000236540.3 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.046306202 |
Sensitive |
| ENSG00000236986.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.037228033 |
Sensitive |
| ENSG00000237253.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.024563434 |
Sensitive |
| ENSG00000237399.3 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.047292405 |
Sensitive |
| ENSG00000237753.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.006808646 |
Sensitive |
| ENSG00000237862.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.035540006 |
Sensitive |
| ENSG00000237892.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.014610768 |
Sensitive |
| ENSG00000239300.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.044241854 |
Sensitive |
| ENSG00000240497.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.029574289 |
Sensitive |
| ENSG00000241985.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.019947174 |
Sensitive |
| ENSG00000244124.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.028944934 |
Sensitive |
| ENSG00000244327.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.017181961 |
Sensitive |
| ENSG00000244945.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.012969784 |
Sensitive |
| ENSG00000245598.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.012796682 |
Sensitive |
| ENSG00000245748.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.045004324 |
Sensitive |
| ENSG00000246250.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.00217672 |
Sensitive |
| ENSG00000248223.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.036153046 |
Sensitive |
| ENSG00000249602.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.039851095 |
Sensitive |
| ENSG00000250133.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.017582242 |
Sensitive |
| ENSG00000250659.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.022465605 |
Sensitive |
| ENSG00000251009.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.027244947 |
Sensitive |
| ENSG00000251323.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.03688375 |
Sensitive |
| ENSG00000253106.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.048153089 |
Sensitive |
| ENSG00000253327.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.039566804 |
Sensitive |
| ENSG00000253476.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.039601121 |
Sensitive |
| ENSG00000253632.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.023795215 |
Sensitive |
| ENSG00000254341.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.026296053 |
Sensitive |
| ENSG00000254428.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.038960772 |
Sensitive |
| ENSG00000254694.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.027438587 |
Sensitive |
| ENSG00000255343.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.021065781 |
Sensitive |
| ENSG00000255348.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.01939643 |
Sensitive |
| ENSG00000255857.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.023935265 |
Sensitive |
| ENSG00000255970.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.032750691 |
Sensitive |
| ENSG00000256268.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.027490218 |
Sensitive |
| ENSG00000256433.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.032312318 |
Sensitive |
| ENSG00000256458.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.009132155 |
Sensitive |
| ENSG00000256746.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.025629528 |
Sensitive |
| ENSG00000257222.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.047238046 |
Sensitive |
| ENSG00000257337.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.048874988 |
Sensitive |
| ENSG00000257354.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.008576064 |
Sensitive |
| ENSG00000257475.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.029094059 |
Sensitive |
| ENSG00000257497.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.035353023 |
Sensitive |
| ENSG00000257596.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.006784032 |
Sensitive |
| ENSG00000257696.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.046739873 |
Sensitive |
| ENSG00000257702.3 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.045756421 |
Sensitive |
| ENSG00000257740.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.015823967 |
Sensitive |
| ENSG00000257809.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.018915698 |
Sensitive |
| ENSG00000257925.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.04548263 |
Sensitive |
| ENSG00000257964.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.036165417 |
Sensitive |
| ENSG00000258057.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.026330129 |
Sensitive |
| ENSG00000258122.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.014441416 |
Sensitive |
| ENSG00000258334.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.022334948 |
Sensitive |
| ENSG00000258344.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.018338254 |
Sensitive |
| ENSG00000258441.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.015722589 |
Sensitive |
| ENSG00000258450.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.040163038 |
Sensitive |
| ENSG00000258725.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.018757044 |
Sensitive |
| ENSG00000258959.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.04027938 |
Sensitive |
| ENSG00000259088.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.015283004 |
Sensitive |
| ENSG00000259364.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.03627557 |
Sensitive |
| ENSG00000259416.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.024778422 |
Sensitive |
| ENSG00000259456.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.000860644 |
Sensitive |
| ENSG00000259515.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.004569726 |
Sensitive |
| ENSG00000260017.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.027891883 |
Sensitive |
| ENSG00000260034.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.032871276 |
Sensitive |
| ENSG00000260179.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.008446088 |
Sensitive |
| ENSG00000260213.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.022548047 |
Sensitive |
| ENSG00000260328.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.01973535 |
Sensitive |
| ENSG00000260589.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.025983306 |
Sensitive |
| ENSG00000260597.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.008484277 |
Sensitive |
| ENSG00000260837.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.016131602 |
Sensitive |
| ENSG00000261015.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.043275378 |
Sensitive |
| ENSG00000261098.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.022789365 |
Sensitive |
| ENSG00000261117.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.033031462 |
Sensitive |
| ENSG00000261124.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.030712613 |
Sensitive |
| ENSG00000261186.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.047416087 |
Sensitive |
| ENSG00000261266.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.029424264 |
Sensitive |
| ENSG00000261286.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.025790922 |
Sensitive |
| ENSG00000261288.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.021377375 |
Sensitive |
| ENSG00000261471.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.016320224 |
Sensitive |
| ENSG00000261490.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.005523026 |
Sensitive |
| ENSG00000261596.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.040551596 |
Sensitive |
| ENSG00000261613.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.012304584 |
Sensitive |
| ENSG00000262089.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.031822992 |
Sensitive |
| ENSG00000262147.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.043353715 |
Sensitive |
| ENSG00000262434.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.008369272 |
Sensitive |
| ENSG00000262652.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.025125913 |
Sensitive |
| ENSG00000262686.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.046665199 |
Sensitive |
| ENSG00000262692.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.018076924 |
Sensitive |
| ENSG00000262766.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.012462455 |
Sensitive |
| ENSG00000262833.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.039904997 |
Sensitive |
| ENSG00000263272.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.01905623 |
Sensitive |
| ENSG00000263393.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.025503346 |
Sensitive |
| ENSG00000263731.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.010185342 |
Sensitive |
| ENSG00000263859.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.020523561 |
Sensitive |
| ENSG00000264270.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.014965808 |
Sensitive |
| ENSG00000264456.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.038032956 |
Sensitive |
| ENSG00000264769.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.019631876 |
Sensitive |
| ENSG00000264829.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.001097527 |
Sensitive |
| ENSG00000265205.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.039254698 |
Sensitive |
| ENSG00000265688.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.031092792 |
Sensitive |
| ENSG00000266236.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.01088557 |
Sensitive |
| ENSG00000266805.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.010840016 |
Sensitive |
| ENSG00000267009.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.036260991 |
Sensitive |
| ENSG00000267096.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.038756963 |
Sensitive |
| ENSG00000267302.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.045877949 |
Sensitive |
| ENSG00000267649.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.048432055 |
Sensitive |
| ENSG00000268199.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.023640066 |
Sensitive |
| ENSG00000268366.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.038832457 |
Sensitive |
| ENSG00000268520.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.027667561 |
Sensitive |
| ENSG00000268812.2 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.00318248 |
Sensitive |
| ENSG00000268947.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.024589769 |
Sensitive |
| ENSG00000269688.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.010025007 |
Sensitive |
| ENSG00000269901.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.016856433 |
Sensitive |
| ENSG00000269987.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.020281111 |
Sensitive |
| ENSG00000270084.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.01301469 |
Sensitive |
| ENSG00000270116.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.032598348 |
Sensitive |
| ENSG00000270557.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.04464055 |
Sensitive |
| ENSG00000270760.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.040334711 |
Sensitive |
| ENSG00000271327.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.039804443 |
Sensitive |
| ENSG00000271555.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.018725513 |
Sensitive |
| ENSG00000271803.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.043373013 |
Sensitive |
| ENSG00000271966.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.000322914 |
Sensitive |
| ENSG00000272030.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.002483165 |
Sensitive |
| ENSG00000272211.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.014420385 |
Sensitive |
| ENSG00000272216.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.022132365 |
Sensitive |
| ENSG00000272379.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.024990818 |
Sensitive |
| ENSG00000272660.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.002749468 |
Sensitive |
| ENSG00000272669.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.015592099 |
Sensitive |
| ENSG00000272836.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.043574037 |
Sensitive |
| ENSG00000272885.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.032197902 |
Sensitive |
| ENSG00000273035.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.021770506 |
Sensitive |
| ENSG00000273076.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.022890063 |
Sensitive |
| ENSG00000273216.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.037593594 |
Sensitive |
| ENSG00000273243.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.014742125 |
Sensitive |
| ENSG00000273271.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.044598036 |
Sensitive |
| ENSG00000273350.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.022304562 |
Sensitive |
| ENSG00000273451.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.006495238 |
Sensitive |
| ENSG00000149656.4 |
ABT-263 (navitoclax) |
Sarcoma |
0.04315554 |
Sensitive |
| ENSG00000172965.10 |
ABT-263 (navitoclax) |
Sarcoma |
0.020879169 |
Sensitive |
| ENSG00000179935.5 |
ABT-263 (navitoclax) |
Sarcoma |
0.011574482 |
Sensitive |
| ENSG00000182586.3 |
ABT-263 (navitoclax) |
Sarcoma |
0.020697378 |
Sensitive |
| ENSG00000188660.3 |
ABT-263 (navitoclax) |
Sarcoma |
0.022779153 |
Sensitive |
| ENSG00000204011.4 |
ABT-263 (navitoclax) |
Sarcoma |
0.044518715 |
Sensitive |
| ENSG00000204685.5 |
ABT-263 (navitoclax) |
Sarcoma |
0.039842696 |
Sensitive |
| ENSG00000204837.2 |
ABT-263 (navitoclax) |
Sarcoma |
0.029262103 |
Sensitive |
| ENSG00000213963.2 |
ABT-263 (navitoclax) |
Sarcoma |
0.044544592 |
Sensitive |
| ENSG00000223393.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.017319246 |
Sensitive |
| ENSG00000223704.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.028009547 |
Sensitive |
| ENSG00000224985.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.023468574 |
Sensitive |
| ENSG00000225684.3 |
ABT-263 (navitoclax) |
Sarcoma |
0.018984482 |
Sensitive |
| ENSG00000225806.3 |
ABT-263 (navitoclax) |
Sarcoma |
0.036375095 |
Sensitive |
| ENSG00000226007.2 |
ABT-263 (navitoclax) |
Sarcoma |
0.029762171 |
Sensitive |
| ENSG00000230021.3 |
ABT-263 (navitoclax) |
Sarcoma |
0.026708681 |
Sensitive |
| ENSG00000230487.3 |
ABT-263 (navitoclax) |
Sarcoma |
0.008605618 |
Sensitive |
| ENSG00000231290.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.016348305 |
Sensitive |
| ENSG00000232160.2 |
ABT-263 (navitoclax) |
Sarcoma |
0.006045127 |
Sensitive |
| ENSG00000233766.3 |
ABT-263 (navitoclax) |
Sarcoma |
0.013319607 |
Sensitive |
| ENSG00000234350.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.022195095 |
Sensitive |
| ENSG00000234617.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.034566873 |
Sensitive |
| ENSG00000234899.5 |
ABT-263 (navitoclax) |
Sarcoma |
0.017470689 |
Sensitive |
| ENSG00000235079.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.026084286 |
Sensitive |
| ENSG00000235664.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.049562948 |
Sensitive |
| ENSG00000236861.2 |
ABT-263 (navitoclax) |
Sarcoma |
0.006859305 |
Sensitive |
| ENSG00000237781.2 |
ABT-263 (navitoclax) |
Sarcoma |
0.032742119 |
Sensitive |
| ENSG00000240401.4 |
ABT-263 (navitoclax) |
Sarcoma |
0.027622732 |
Sensitive |
| ENSG00000240453.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.032679626 |
Sensitive |
| ENSG00000240990.5 |
ABT-263 (navitoclax) |
Sarcoma |
0.018402316 |
Sensitive |
| ENSG00000242687.2 |
ABT-263 (navitoclax) |
Sarcoma |
0.034766127 |
Sensitive |
| ENSG00000247970.2 |
ABT-263 (navitoclax) |
Sarcoma |
0.04396937 |
Sensitive |
| ENSG00000250155.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.03478052 |
Sensitive |
| ENSG00000250948.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.029100269 |
Sensitive |
| ENSG00000254353.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.025107694 |
Sensitive |
| ENSG00000258082.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.029643414 |
Sensitive |
| ENSG00000258413.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.039039305 |
Sensitive |
| ENSG00000258515.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.032575501 |
Sensitive |
| ENSG00000258689.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.037979104 |
Sensitive |
| ENSG00000259863.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.02408382 |
Sensitive |
| ENSG00000260336.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.016008917 |
Sensitive |
| ENSG00000260837.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.000694542 |
Sensitive |
| ENSG00000261295.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.02870834 |
Sensitive |
| ENSG00000261578.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.0023254 |
Sensitive |
| ENSG00000261644.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.02799087 |
Sensitive |
| ENSG00000263466.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.010338794 |
Sensitive |
| ENSG00000268049.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.041215952 |
Sensitive |
| ENSG00000270171.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.018503261 |
Sensitive |
| ENSG00000271324.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.019005826 |
Sensitive |
| ENSG00000271824.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.007856087 |
Sensitive |
| ENSG00000188660.3 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.04975478 |
Sensitive |
| ENSG00000197308.4 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.003348976 |
Sensitive |
| ENSG00000225234.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.04531946 |
Sensitive |
| ENSG00000230212.2 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.0000157 |
Sensitive |
| ENSG00000230530.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.003282433 |
Sensitive |
| ENSG00000232504.4 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.049903049 |
Sensitive |
| ENSG00000233058.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.01447129 |
Sensitive |
| ENSG00000237281.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.010422301 |
Sensitive |
| ENSG00000237989.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.002675671 |
Sensitive |
| ENSG00000242516.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.004731433 |
Sensitive |
| ENSG00000249131.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.025076091 |
Sensitive |
| ENSG00000253390.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.015014775 |
Sensitive |
| ENSG00000258199.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.020322733 |
Sensitive |
| ENSG00000259415.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.019641996 |
Sensitive |
| ENSG00000259644.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.045216968 |
Sensitive |
| ENSG00000259876.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.042752148 |
Sensitive |
| ENSG00000260194.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.019227472 |
Sensitive |
| ENSG00000260637.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.04524003 |
Sensitive |
| ENSG00000261095.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.031332772 |
Sensitive |
| ENSG00000261864.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.033054802 |
Sensitive |
| ENSG00000262313.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.024956089 |
Sensitive |
| ENSG00000263063.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.000552409 |
Sensitive |
| ENSG00000264304.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.003743112 |
Sensitive |
| ENSG00000267279.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.032591733 |
Sensitive |
| ENSG00000267282.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.019879992 |
Sensitive |
| ENSG00000267852.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.032143036 |
Sensitive |
| ENSG00000268970.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.041800216 |
Sensitive |
| ENSG00000269480.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.025983869 |
Sensitive |
| ENSG00000270117.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.027889375 |
Sensitive |
| ENSG00000272386.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.01148744 |
Sensitive |
| ENSG00000272483.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.033342436 |
Sensitive |
| ENSG00000272858.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.039997387 |
Sensitive |
| ENSG00000272859.1 |
ABT-263 (navitoclax) |
Skin cutaneous melanoma |
0.013098045 |
Sensitive |
